Amedeo Smart

Free Medical Literature Service


 

Amedeo

Dermatology

  Free Subscription

Articles published in
Br J Dermatol
    August 2022
  1. BELL KJL, Nijsten T
    Melanoma overdiagnosis: why it matters and what can be done about it.
    Br J Dermatol. 2022 Aug 5. doi: 10.1111/bjd.21750.
    >> Share

  2. FENG Y, Lu Y, Wang H
    Leucoderma secondary to wig wearing.
    Br J Dermatol. 2022;187:e64.
    >> Share


  3. Better understanding about the severity of disease in cutaneous T-cell lymphoma from studying immune checkpoint receptors.
    Br J Dermatol. 2022;187:e69-e76.
    >> Share

  4. GARG A, Zema C, Kim K, Gao W, et al
    Development and initial validation of the HS-IGA: a novel hidradenitis suppurativa-specific investigator global assessment for use in interventional trials.
    Br J Dermatol. 2022;187:203-210.
    >> Share

  5. BIRABAHARAN M, Kaelber DC, Orme CM, Paravar T, et al
    Evaluating risk of bullous pemphigoid after mRNA COVID-19 vaccination.
    Br J Dermatol. 2022;187:271-273.
    >> Share

  6. LIU Y, Tan Y, Liu J, Song Z, et al
    Novel and founder variants of SERPINA12 in Chinese patients with autosomal recessive palmoplantar keratoderma.
    Br J Dermatol. 2022;187:267-270.
    >> Share

  7. DI RAIMONDO C, Rubio-Gonzalez B, Palmer J, Weisenburger DD, et al
    Expression of immune checkpoint molecules programmed death protein 1, programmed death-ligand 1 and inducible T-cell co-stimulator in mycosis fungoides and Sezary syndrome: association with disease stage and clinical outcome.
    Br J Dermatol. 2022;187:234-243.
    >> Share

  8. JIANG TT, Kruglov O, Geskin L, Akilov OE, et al
    Repetitive expanded T-cell receptor clonotypes impart the classic T helper 2 Sezary cell phenotype.
    Br J Dermatol. 2022;187:265-267.
    >> Share

  9. BAE JM, Kim M, Han JH, Lee S, et al
    Preventive effect of levodopa on vitiligo development: a nationwide case-control study.
    Br J Dermatol. 2022;187:259-261.
    >> Share

  10. RING HC, Thomsen SF
    The impact of Janus kinase 1 inhibitors on quality of life in patients with hidradenitis suppurativa.
    Br J Dermatol. 2022;187:274.
    >> Share

  11. YUKSEL YT, Ibler K, Agner T, Ofenloch R, et al
    Validation of the Danish version of the Quality of Life in Hand Eczema Questionnaire (QOLHEQ).
    Br J Dermatol. 2022;187:256-258.
    >> Share

  12. DE VERE HUNT I, Halley M, Sum K, Yekrang K, et al
    A qualitative exploration of the experiences of itch for adults living with epidermolysis bullosa.
    Br J Dermatol. 2022;187:261-263.
    >> Share

  13. BUECHLER CR, Sagher E, Tisack A, Jacobsen G, et al
    Demographic factors and disparate outcomes in mycosis fungoides: retrospective analysis of a racially diverse 440-patient cohort from Detroit, Michigan, USA.
    Br J Dermatol. 2022;187:246-248.
    >> Share

  14. SINGH R, Mohammed A, Senthilnathan A, Feldman SR, et al
    Hidradenitis suppurativa may impact clothing patterns even in patients with mild disease and symptoms: an observational study.
    Br J Dermatol. 2022;187:250-251.
    >> Share

  15. MORGAN CL, Thomas M, Stander S, Jabbar-Lopez ZK, et al
    Epidemiology of prurigo nodularis in England: a retrospective database analysis.
    Br J Dermatol. 2022;187:188-195.
    >> Share

    July 2022
  16. VAN DER SCHOOT LS, Atalay S, Otero ME, Kievit W, et al
    Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab.
    Br J Dermatol. 2022 Jul 27. doi: 10.1111/bjd.21797.
    >> Share

  17. WANG L, Rocas D, Dalle S, Sako N, et al
    Primary cutaneous peripheral T-cell lymphomas with a T follicular helper phenotype: An integrative clinical, pathological, and molecular case series study.
    Br J Dermatol. 2022 Jul 27. doi: 10.1111/bjd.21791.
    >> Share

  18. SHARIATMADARI I, Matteucci P, Barreda A, O'Toole L, et al
    Response to 'British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021': Vismodegib and indications for its use.
    Br J Dermatol. 2022 Jul 23. doi: 10.1111/bjd.21788.
    >> Share

  19. ORMEROD AD
    Predicting the outcome of psoriasis treatment.
    Br J Dermatol. 2022 Jul 22. doi: 10.1111/bjd.21747.
    >> Share

  20. VISCONTI A, Murray B, Rossi N, Wolf J, et al
    Cutaneous Manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348,691 UK users of the UK ZOE COVID Study App.
    Br J Dermatol. 2022 Jul 22. doi: 10.1111/bjd.21784.
    >> Share

  21. LAURENT C, Lefevre G, Kahn JE, Staumont-Salle D, et al
    Cutaneous manifestations of lymphoid-variant hypereosinophilic syndrome.
    Br J Dermatol. 2022 Jul 21. doi: 10.1111/bjd.21782.
    >> Share

  22. NIKOLAOU V, Apalla Z, Carrera C, Fattore D, et al
    Clinical associations and classification of immune checkpoint inhibitors-induced cutaneous toxicities: A multicentric study from the EADV-Task Force of Dermatology for Cancer Patients.
    Br J Dermatol. 2022 Jul 21. doi: 10.1111/bjd.21781.
    >> Share

  23. CHOON SE, Wright AK, Griffiths CEM, Tey KE, et al
    Incidence and prevalence of psoriasis in multi-ethnic Johor Bahru, Malaysia: a population-based cohort study using electronic health data routinely captured in Teleprimary Care (TPC(R)) clinical information system from 2010 to 2020.
    Br J Dermatol. 2022 Jul 13. doi: 10.1111/bjd.21768.
    >> Share

  24. NAGTZAAM IF, van Leersum FS, Kouwenberg LCM, Blok MJ, et al
    STS pathogenic variants in a Dutch patient cohort clinically suspected for X-linked ichthyosis shows genetic heterogeneity.
    Br J Dermatol. 2022 Jul 13. doi: 10.1111/bjd.21775.
    >> Share

  25. MOHAMAD J, Sarig O, Beattie P, Malovitski K, et al
    A unique skin phenotype resulting from a large heterozygous deletion spanning six keratin genes.
    Br J Dermatol. 2022 Jul 13. doi: 10.1111/bjd.21766.
    >> Share

  26. YANG N, Chen L, Shao J, Jiang F, et al
    Dupilumab with concomitant JAK inhibitor: A novel treatment strategy for atopic dermatitis with poor response to dupilumab.
    Br J Dermatol. 2022 Jul 13. doi: 10.1111/bjd.21776.
    >> Share

  27. ROCCUZZO G, Fava P, Avallone G, Aquino C, et al
    Time to next treatment and safety assessment in Cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin.
    Br J Dermatol. 2022 Jul 13. doi: 10.1111/bjd.21772.
    >> Share

  28. ARNOLD S, Fernando S, Rees S
    Living with Vulval Lichen Sclerosus: a qualitative interview study.
    Br J Dermatol. 2022 Jul 13. doi: 10.1111/bjd.21777.
    >> Share

  29. FROMME M, Schneider CV, Schlapbach C, Cazzaniga S, et al
    Comorbidities in lichen planus by phenome-wide association study in two biobank population cohorts.
    Br J Dermatol. 2022 Jul 12. doi: 10.1111/bjd.21762.
    >> Share

  30. RUIZ GENAO DP, Carretero G, Rivera-Diaz R, Carrascosa JM, et al
    Differences in epidemiology, comorbidities and treatment choice between plaque psoriasis and pustular psoriasis: results from the Biobadaderm registry.
    Br J Dermatol. 2022 Jul 12. doi: 10.1111/bjd.21763.
    >> Share

  31. BLAUVELT A, Kimball AB, Augustin M, Okubo Y, et al
    Efficacy and Safety of Mirikizumab in Psoriasis: Results from a 52-Week, Double-Blinded, Placebo-Controlled, Randomised Withdrawal, Phase III Trial (OASIS-1).
    Br J Dermatol. 2022 Jul 6. doi: 10.1111/bjd.21743.
    >> Share


  32. British Society for Investigative Dermatology Virtual Annual Meeting, 29-31 March 2021.
    Br J Dermatol. 2022;187:e1-e63.
    >> Share

  33. HUNT N
    Identity and psychological distress in alopecia areata.
    Br J Dermatol. 2022;187:9-10.
    >> Share

  34. SCHUTTELAAR MLA
    A new avenue for treatment of chronic hand eczema.
    Br J Dermatol. 2022;187:7-8.
    >> Share

  35. RAVENCROFT J, Eichenfield L
    Isotretinoin does not contribute to increased neuropsychiatric risk in the overall acne population, but risk management during treatment remains essential.
    Br J Dermatol. 2022;187:8-9.
    >> Share

  36. PALJARVI T, McPherson T, Luciano S, Herttua K, et al
    Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data.
    Br J Dermatol. 2022;187:64-72.
    >> Share

  37. MACBETH AE, Holmes S, Harries M, Chiu WS, et al
    The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care.
    Br J Dermatol. 2022;187:73-81.
    >> Share

  38. WORM M, Thyssen JP, Schliemann S, Bauer A, et al
    The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial.
    Br J Dermatol. 2022;187:42-51.
    >> Share

  39. WANG J, Ram-Wolff C, Dobos G, Al Hage J, et al
    Head and neck granulomatous rash associated with mogamulizumab mimicking mycosis fungoides.
    Br J Dermatol. 2022;187:129-131.
    >> Share

  40. HEWITT RM, Bundy C, Newi AL, Chachos E, et al
    How do dermatologists' personal models inform a patient-centred approach to management: a qualitative study using the example of prescribing a new treatment (Apremilast).
    Br J Dermatol. 2022;187:82-88.
    >> Share


  41. Eumelanin Human Skin Colour Scale: proof-of-concept study.
    Br J Dermatol. 2022;187:vi.
    >> Share

    June 2022
  42. WEI J, Zhu J, Xu H, Zhou D, et al
    Alcohol consumption and smoking in relation to psoriasis: a Mendelian randomization study.
    Br J Dermatol. 2022 Jun 28. doi: 10.1111/bjd.21718.
    >> Share

  43. SANTANDREA G, Valli R, Ragazzi M, Castagnetti F, et al
    Clinically unquestionable but histologically deceptive melanomas in acral skin grafts: PRAME confirms its role.
    Br J Dermatol. 2022 Jun 28. doi: 10.1111/bjd.21715.
    >> Share

  44. VONK J, de Wit JG, Voskuil FJ, Koldijk M, et al
    Fluorescence molecular imaging using cetuximab-800CW in cutaneous squamous cell carcinoma surgery: a proof-of-concept study.
    Br J Dermatol. 2022 Jun 28. doi: 10.1111/bjd.21722.
    >> Share

  45. SCHNEEWEISS MC, Kirchgesner J, Wyss R, Jin Y, et al
    Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study.
    Br J Dermatol. 2022 Jun 19. doi: 10.1111/bjd.21704.
    >> Share

  46. CALBET-LLOPART N, Combalia M, Kiroglu A, Potrony M, et al
    Common genetic variants associated with melanoma risk or naevus count in wild-type MC1R melanoma patients.
    Br J Dermatol. 2022 Jun 14. doi: 10.1111/bjd.21707.
    >> Share

  47. AGUILAR-DURAN S, Mee J, Popat S, Heelan K, et al
    Atezolizumab-induced linear IgA bullous dermatosis.
    Br J Dermatol. 2022 Jun 7. doi: 10.1111/bjd.21653.
    >> Share

  48. FAN R, Leasure AC, Maisha FI, Little AJ, et al
    Thyroid disorders associated with lichen sclerosus: A case-control study in the All of Us research program.
    Br J Dermatol. 2022 Jun 6. doi: 10.1111/bjd.21702.
    >> Share

  49. BATTESTI G, Ram-Wolff C, Dobos G, Aubin F, et al
    Granulomatous slack skin: clinical characteristics, prognosis, and response to therapy. A study from the Cutaneous Lymphoma French Study Group.
    Br J Dermatol. 2022 Jun 6. doi: 10.1111/bjd.21699.
    >> Share

  50. ITO M, Kamata M, Uchida H, Egawa S, et al
    Ixekizumab rapidly improves inflammatory markers in patients with generalized pustular psoriasis.
    Br J Dermatol. 2022 Jun 6. doi: 10.1111/bjd.21701.
    >> Share

  51. PENG C, Jian X, Xie Y, Li L, et al
    Genomic alterations of dermatofibrosarcoma protuberans revealed by whole-genome sequencing.
    Br J Dermatol. 2022;186:997-1009.
    >> Share

  52. OFENLOCH R, Grochulska K, Mettang T, Weisshaar E, et al
    The incidence of chronic itch in patients on haemodialysis and associated factors.
    Br J Dermatol. 2022;186:1052-1054.
    >> Share

  53. ROELENS M, de Masson A, Andrillon A, Ram-Wolff C, et al
    Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sezary syndrome.
    Br J Dermatol. 2022;186:1010-1025.
    >> Share

  54. BETTUZZI T, Hua C, Diaz E, Colin A, et al
    Epidermal necrolysis: characterization of different phenotypes using an unsupervised clustering analysis.
    Br J Dermatol. 2022;186:1037-1039.
    >> Share

  55. MIN MS, Kus K, Wei N, Kassamali B, et al
    Evaluating the role of histopathology in diagnosing pyoderma gangrenosum using Delphi and PARACELSUS criteria: a multicentre, retrospective cohort study.
    Br J Dermatol. 2022;186:1035-1037.
    >> Share

    May 2022
  56. THAM KC, Lefferdink R, Duan K, Lim SS, et al
    Distinct skin microbiome community structures in congenital ichthyosis.
    Br J Dermatol. 2022 May 28. doi: 10.1111/bjd.21687.
    >> Share

  57. SINGAL A, Mehta S
    Eumelanin Human Skin Colour Scale: a novel concept with potential for further refinement.
    Br J Dermatol. 2022 May 28. doi: 10.1111/bjd.21652.
    >> Share

  58. MIURA H, Fujiwara S
    Successful treatment of severe subcorneal pustular dermatosis with the 308-nm ultraviolet B excimer laser.
    Br J Dermatol. 2022 May 28. doi: 10.1111/bjd.21633.
    >> Share

  59. RICCI F, Abeni D
    Heterogeneity of reports about the impact of the COVID-19 pandemic on melanoma diagnosis.
    Br J Dermatol. 2022 May 24. doi: 10.1111/bjd.21598.
    >> Share

  60. OLSEN CM
    International surveillance of trends in melanoma survival: the impact of morphology.
    Br J Dermatol. 2022 May 24. doi: 10.1111/bjd.21651.
    >> Share

  61. HAN J, O'Neal S, Gravely A, Linos E, et al
    United States Academic Dermatologists' Attitudes Towards Active Surveillance for Basal Cell Carcinoma.
    Br J Dermatol. 2022 May 23. doi: 10.1111/bjd.21675.
    >> Share

  62. MARTIN-MORO F, Martin-Rubio I, Garcia-Vela JA
    TRBC1 expression assessed by flow cytometry as a novel marker of clonality in cutaneous alphabeta T-cell lymphomas with peripheral blood involvement.
    Br J Dermatol. 2022 May 23. doi: 10.1111/bjd.21678.
    >> Share

  63. CORBETT M, Ramessur R, Marshall D, Acencio ML, et al
    Biomarkers of systemic treatment response in people with psoriasis: a scoping review.
    Br J Dermatol. 2022 May 23. doi: 10.1111/bjd.21677.
    >> Share

  64. KAMMINGA NCW, van der Veldt AAM, Joosen MCW, de Joode K, et al
    Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma.
    Br J Dermatol. 2022 May 21. doi: 10.1111/bjd.21670.
    >> Share

  65. LANGAN EA, Kunstner A
    The gastrointestinal microbiome and psoriasis: more food for thought.
    Br J Dermatol. 2022 May 20. doi: 10.1111/bjd.21618.
    >> Share

  66. BALAK DMW, Lambert J
    Weighing in on weight-based secukinumab dosing for psoriasis.
    Br J Dermatol. 2022 May 16. doi: 10.1111/bjd.21607.
    >> Share

  67. PONTES FSC, Pereira GG, da Silva Santos PS, Pontes HAR, et al
    Isotretinoin and herpes simplex virus infection.
    Br J Dermatol. 2022 May 11. doi: 10.1111/bjd.21610.
    >> Share

  68. SCHEEL CH, Rached NA, Gambichler T
    Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum.
    Br J Dermatol. 2022 May 9. doi: 10.1111/bjd.21591.
    >> Share

  69. WHITEMAN DC, Olsen CM, MacGregor S, Law MH, et al
    The effect of screening on melanoma incidence and biopsy rates.
    Br J Dermatol. 2022 May 9. doi: 10.1111/bjd.21649.
    >> Share

  70. COLE EF, Mustin DE, Feldman RJ
    The Effect of Race and Fitzpatrick Skin Type on Bullous Pemphigoid Disease Area Index (BPDAI) Scores.
    Br J Dermatol. 2022 May 9. doi: 10.1111/bjd.21648.
    >> Share

  71. CAPON F
    New genetic and clinical features of neonatal inflammatory skin and bowel disease 1.
    Br J Dermatol. 2022 May 6. doi: 10.1111/bjd.21589.
    >> Share

  72. DISSEMOND J, Romanelli M
    Inflammatory skin diseases and wounds.
    Br J Dermatol. 2022 May 6. doi: 10.1111/bjd.21619.
    >> Share

  73. SCHUMMER P, Schilling B
    How representative are data from global trials on programmed death-1 blockade in melanoma?
    Br J Dermatol. 2022 May 4. doi: 10.1111/bjd.21621.
    >> Share

  74. LEONARDI-BEE J, Drucker AM
    Systemic treatments for psoriasis: not another network meta-analysis!
    Br J Dermatol. 2022 May 3. doi: 10.1111/bjd.21601.
    >> Share

  75. MAGIN P, Fisher K
    Body dysmorphic disorder, skin diseases and psychological morbidity: common and complex.
    Br J Dermatol. 2022 May 3. doi: 10.1111/bjd.21586.
    >> Share

  76. CARRERA C, Podlipnik S
    Does acral melanoma need a distinctive prognostic staging system?
    Br J Dermatol. 2022 May 3. doi: 10.1111/bjd.21585.
    >> Share

  77. BACHELEZ H
    Is heat shock protein 90 inhibition a relevant treatment strategy for psoriasis?
    Br J Dermatol. 2022;186:771-772.
    >> Share

  78. BAARDMAN R, Bolling MC
    The importance of accurate epidemiological data of epidermolysis bullosa.
    Br J Dermatol. 2022;186:765-766.
    >> Share

  79. KLEIN TM
    Content validity of five single-item instruments in adolescents with alopecia areata.
    Br J Dermatol. 2022;186:763-764.
    >> Share


  80. Findings from a survey about hidradenitis suppurativa in the Netherlands.
    Br J Dermatol. 2022;186:e200-e219.
    >> Share

  81. KEARNEY N, Kirby B
    The prevalence of hidradenitis suppurativa outside the hospital setting: the impact of the undiagnosed.
    Br J Dermatol. 2022;186:767-768.
    >> Share

  82. SIBBALD C, Alhusayen R
    Janus kinase inhibitors for hidradenitis suppurativa: expanding the therapeutic toolbox.
    Br J Dermatol. 2022;186:768-769.
    >> Share

  83. ALAVI A, Hamzavi I, Brown K, Santos LL, et al
    Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: results from two phase II studies.
    Br J Dermatol. 2022;186:803-813.
    >> Share

  84. CHEN CW, Wei JC
    Response to 'Validation of generalized drug-related rash diagnoses using International Classification of Diseases 9th and 10th Revision codes'.
    Br J Dermatol. 2022;186:910-911.
    >> Share

  85. GOLDENBERG M, Krishna SG, Milani-Nejad N, Trinidad JC, et al
    Response to: 'Validation of generalized drug-related rash diagnoses using International Classification of Diseases 9(th) and 10(th) Revision codes': reply from the authors.
    Br J Dermatol. 2022;186:911.
    >> Share

  86. WONGVIBULSIN S, Parthasarathy V, Pahalyants V, Murphy W, et al
    Latent class analysis identification of prurigo nodularis comorbidity phenotypes.
    Br J Dermatol. 2022;186:903-905.
    >> Share

  87. PETROF G, Papanikolaou M, Martinez AE, Mellerio JE, et al
    The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa database.
    Br J Dermatol. 2022;186:843-848.
    >> Share

  88. BARRANCA A, Debarbieux S, Tancrede-Bohin E, Saillard C, et al
    A nationwide study evaluating the association of autoimmune bullous diseases and acquired haemophilia: description of clinical and prognostic features.
    Br J Dermatol. 2022;186:899-902.
    >> Share

  89. YATSUZUKA K, Murakami M
    Response to 'Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)'.
    Br J Dermatol. 2022;186:908.
    >> Share

  90. CRO S, Smith CH
    Response to: 'Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)': reply from the authors.
    Br J Dermatol. 2022;186:909-910.
    >> Share

  91. MACEY J, Kitchen H, Aldhouse NVJ, Edson-Heredia E, et al
    A qualitative interview study to explore adolescents' experience of alopecia areata and the content validity of sign/symptom patient-reported outcome measures.
    Br J Dermatol. 2022;186:849-860.
    >> Share

  92. WAKKEE M
    Polygenic risk scores for melanoma: a stepwise process towards clinical implementation.
    Br J Dermatol. 2022;186:768.
    >> Share

    April 2022
  93. FLOREZ ID
    Clinical practice guidelines for psoriasis: which ones are the best?
    Br J Dermatol. 2022 Apr 29. doi: 10.1111/bjd.21605.
    >> Share

  94. SAMIMI M
    Is 5-fluorouracil the best candidate for topical chemoprevention of skin cancers in organ transplant recipients?
    Br J Dermatol. 2022 Apr 28. doi: 10.1111/bjd.21602.
    >> Share

  95. ZHUANG K, Ran Y
    Primary cutaneous nocardiosis caused by a novel Nocardia species.
    Br J Dermatol. 2022 Apr 28. doi: 10.1111/bjd.21599.
    >> Share

  96. CHOON SE, Bachelez H
    Time to accurately determine the burden of generalized pustular psoriasis at the population level.
    Br J Dermatol. 2022 Apr 28. doi: 10.1111/bjd.21588.
    >> Share

  97. LEMMENS VEPP, Louwman MWJ
    Basal cell carcinoma, an often unjustly overlooked healthcare challenge.
    Br J Dermatol. 2022 Apr 28. doi: 10.1111/bjd.21587.
    >> Share

  98. BIEBER T, Reich K, Paul C, Tsunemi Y, et al
    Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Patients With Moderate-to-Severe Atopic Dermatitis With Inadequate Response, Intolerance, or Contraindication to Cyclosporine: Results From a Randomized, Placebo-Control
    Br J Dermatol. 2022 Apr 28. doi: 10.1111/bjd.21630.
    >> Share

  99. RAMESSUR R, Corbett M, Marshall D, Acencio ML, et al
    Biomarkers of disease progression in people with psoriasis: a scoping review.
    Br J Dermatol. 2022 Apr 28. doi: 10.1111/bjd.21627.
    >> Share

  100. LAQUER V, Parra V, Lacour JP, Takahashi H, et al
    IL-33 antibody failed to demonstrate benefit in a phase 2 double-blind, randomised placebo-controlled study in adult patients with moderate-to-severe atopic dermatitis.
    Br J Dermatol. 2022 Apr 28. doi: 10.1111/bjd.21631.
    >> Share

  101. JENDOUBI F, Shourik J, Seneschal J, Giordano-Labadie F, et al
    Longer Dupilumab Dosing Intervals in Adult Patients with Atopic Dermatitis: Experience from a French Multicentre Retrospective Cohort Study.
    Br J Dermatol. 2022 Apr 28. doi: 10.1111/bjd.21628.
    >> Share

  102. KWAN Z, Anand RL, Mallipeddi R, Ali FR, et al
    The utility of negative histopathological analysis of debulk specimens during Mohs micrographic surgery for basal cell carcinoma.
    Br J Dermatol. 2022 Apr 20. doi: 10.1111/bjd.21613.
    >> Share

  103. GRIFFIN LR, Ryan S, Ramsay B
    Response to 'Patients with nodular prurigo commonly have pre-existing psychological disease that requires treatment concomitant with cutaneous therapies'.
    Br J Dermatol. 2022 Apr 20. doi: 10.1111/bjd.21616.
    >> Share

  104. REICH K, Cullen E, Weinberg M
    Maintenance of response in moderate-to-severe psoriasis after withdrawal of the IL-17A and IL-17F nanobody sonelokimab - Is there a role for IL-17F in disease reoccurrence?
    Br J Dermatol. 2022 Apr 20. doi: 10.1111/bjd.21617.
    >> Share

  105. SIMPSON EL, Bissonnette R, Paller AS, King B, et al
    The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): A Clinical Outcome Measure for the Severity of Atopic Dermatitis.
    Br J Dermatol. 2022 Apr 20. doi: 10.1111/bjd.21615.
    >> Share

  106. SOLIMAN YS, Mieczkowska K, Zhu TR, Hossain O, et al
    Characterizing Basal Cell Carcinoma in Hispanic Individuals Undergoing Mohs Micrographic Surgery: A 7-year Retrospective Review at an Academic Institution in the Bronx.
    Br J Dermatol. 2022 Apr 20. doi: 10.1111/bjd.21614.
    >> Share

  107. MANOLACHE L, Finlay AY
    Should self-help interventions become routine in psoriasis therapy?
    Br J Dermatol. 2022 Apr 19. doi: 10.1111/bjd.21584.
    >> Share

  108. MAKINO T, Sugiyama H, Oshima M, Mizawa M, et al
    Cutaneous gnathostomiasis caused by Gnathostoma spinigerum.
    Br J Dermatol. 2022 Apr 15. doi: 10.1111/bjd.21007.
    >> Share

  109. HARVIMA IT, Harvima RJ
    Survival from cutaneous malignant melanoma is improving, but is it because of a trend in decreasing melanoma thickness or the advent of new 'revolutionary' therapeutics?
    Br J Dermatol. 2022 Apr 12. doi: 10.1111/bjd.21583.
    >> Share

  110. GJERSVIK P
    The future is hard to predict, even for patients with cutaneous squamous cell carcinoma.
    Br J Dermatol. 2022 Apr 12. doi: 10.1111/bjd.21291.
    >> Share

  111. BLOME C, von Stulpnagel CC, Augustin M, Mrowietz U, et al
    Measuring patient-relevant benefits in psoriasis with the Patient Benefit Index: Development and preliminary validation of a 10-item short form.
    Br J Dermatol. 2022 Apr 5. doi: 10.1111/bjd.21593.
    >> Share

  112. NIELSEN ML, Nymand LK, Thomsen SF, Thyssen JP, et al
    Delay in diagnosis and treatment of patients with psoriasis - a population-based cross-sectional study.
    Br J Dermatol. 2022 Apr 5. doi: 10.1111/bjd.21594.
    >> Share

  113. LOFT N, Skov L, Richardson C, Trivedi V, et al
    A nationwide population-based cohort study of the incidence of severe and rare infections among adults with psoriasis in Denmark.
    Br J Dermatol. 2022 Apr 5. doi: 10.1111/bjd.21595.
    >> Share

  114. NALDI L
    Going global with assessing the acne burden: is the evidence worth the effort?
    Br J Dermatol. 2022;186:605.
    >> Share


  115. Revolutionizing Atopic Dermatitis, 11-13 December 2021.
    Br J Dermatol. 2022;186:e135-e185.
    >> Share

  116. BARBAROT S
    Targeting the itch-scratch vicious circle in atopic eczema.
    Br J Dermatol. 2022;186:608.
    >> Share

  117. SUBRAMANIAM KS, Antoniou MN, McGrath JA, Lwin SM, et al
    The potential of gene therapy for recessive dystrophic epidermolysis bullosa.
    Br J Dermatol. 2022;186:609-619.
    >> Share

  118. KASPERKIEWICZ M, Strong R, Mead K, Yale M, et al
    COVID-19 vaccine acceptance and hesitancy in patients with immunobullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation.
    Br J Dermatol. 2022;186:737-739.
    >> Share

  119. LUCKY AW, Pope E
    Pregnancy in epidermolysis bullosa: long-awaited guidelines of care.
    Br J Dermatol. 2022;186:602-603.
    >> Share

  120. SARKANY RPE, Canfield M, Morgan M, Foster L, et al
    Ultraviolet radiation exposure to the face in patients with xeroderma pigmentosum and healthy controls: applying a novel methodology to define photoprotection behaviour.
    Br J Dermatol. 2022;186:713-720.
    >> Share

  121. GAMBICHLER T, Hamdani N, Budde H, Sieme M, et al
    Bullous pemphigoid after SARS-CoV-2 vaccination: spike-protein-directed immunofluorescence confocal microscopy and T-cell-receptor studies.
    Br J Dermatol. 2022;186:728-731.
    >> Share

  122. CHEN H, Zhang TC, Yin XL, Man JY, et al
    Magnitude and temporal trend of acne vulgaris burden in 204 countries and territories from 1990 to 2019: an analysis from the Global Burden of Disease Study 2019.
    Br J Dermatol. 2022;186:673-683.
    >> Share

  123. RAMIREZ-GARCIALUNA JL, Wang SC, Yangzom T, Piguet V, et al
    Use of thermal imaging and a dedicated wound-imaging smartphone app as an adjunct to staging hidradenitis suppurativa.
    Br J Dermatol. 2022;186:723-726.
    >> Share

  124. RASHID H, Meijer JM, Bolling MC, Horvath B, et al
    Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid.
    Br J Dermatol. 2022;186:721-723.
    >> Share

  125. CHEN XQ, Zheng DY, Xiao YY, Dong BL, et al
    Aetiology of tinea capitis in China: a multicentre prospective study.
    Br J Dermatol. 2022;186:705-712.
    >> Share

  126. GREENBLATT DT, Pillay E, Snelson K, Saad R, et al
    Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline.
    Br J Dermatol. 2022;186:620-632.
    >> Share

    March 2022
  127. DADZIE OE, Sturm RA, Fajuyigbe D, Petit A, et al
    The Eumelanin Human Skin Colour Scale: A Proof-of-Concept Study.
    Br J Dermatol. 2022 Mar 29. doi: 10.1111/bjd.21277.
    >> Share

  128. KATO J, Namikawa K, Uehara J, Nomura M, et al
    Prognoses of melanoma patients who continue/discontinue anti-programmed death-1 therapy after achieving a complete response in a real-world setting: A multicenter retrospective study.
    Br J Dermatol. 2022 Mar 29. doi: 10.1111/bjd.21276.
    >> Share

  129. DI CARLO V, Stiller CA, Eisemann N, Bordoni A, et al
    Does the morphology of cutaneous melanoma help explain the international differences in survival? Results from 1,578,482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).
    Br J Dermatol. 2022 Mar 29. doi: 10.1111/bjd.21274.
    >> Share

  130. SOWTER P, Santibanez-Koref M, Jackson MS, Borthwick GM, et al
    Response to 'Cutaneous squamous cell carcinoma is associated with Lynch syndrome: widening the spectrum of Lynch syndrome-associated tumours'.
    Br J Dermatol. 2022 Mar 24. doi: 10.1111/bjd.20970.
    >> Share

  131. FISCHER K, Aringer M, Steininger J, Heil J, et al
    Improvement of cutaneous inflammation and panniculitis in dermatomyositis patients by the JAK-inhibitor baricitinib.
    Br J Dermatol. 2022 Mar 23. doi: 10.1111/bjd.21252.
    >> Share

  132. KURTANSKY NR, Manci RN, Bello DM, Adamson AS, et al
    Risk of non-acral cutaneous melanoma after the diagnosis of acral melanoma.
    Br J Dermatol. 2022 Mar 23. doi: 10.1111/bjd.21251.
    >> Share

  133. STEFANOVIC N, Fitzmaurice CJ, Ormond P, Irvine AD, et al
    Risk Factors for Distant Metastasis in Cutaneous Squamous Cell Carcinoma.
    Br J Dermatol. 2022 Mar 22. doi: 10.1111/bjd.21250.
    >> Share

  134. BAI X, Shoushtari AN, Betof Warner A, Si L, et al
    Benefit and Toxicity to PD-1 Blockade Varies by Ethnicity in Patients with Advanced Melanoma: An International Multicenter Observational Study.
    Br J Dermatol. 2022 Mar 16. doi: 10.1111/bjd.21241.
    >> Share

  135. JACOBY TV, Otto TS, Asdourian MS, Shah N, et al
    Association of preexisting drug allergies with cutaneous immune related adverse events among patients on immune checkpoint inhibitor therapy.
    Br J Dermatol. 2022 Mar 15. doi: 10.1111/bjd.21243.
    >> Share

  136. TODBERG T, Egeberg A, Zachariae C, Sorensen N, et al
    Patients with psoriasis have a dysbiotic taxonomic and functional gut microbiota.
    Br J Dermatol. 2022 Mar 15. doi: 10.1111/bjd.21245.
    >> Share

  137. REID C, Welsh C, Martin-Smith H, Dharmaprasad S, et al
    A Rapid Access Clinic for Psoriasis - First Experiences.
    Br J Dermatol. 2022 Mar 15. doi: 10.1111/bjd.21242.
    >> Share

  138. PENNY CL, Quow K, Rundle CW, Al-Rohil RN, et al
    Response to 'Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin' :reply from authors.
    Br J Dermatol. 2022 Mar 10. doi: 10.1111/bjd.21239.
    >> Share

  139. OYA K, Nakamura Y, Fujisawa Y, Nomura T, et al
    Response to 'Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin'.
    Br J Dermatol. 2022 Mar 9. doi: 10.1111/bjd.21230.
    >> Share

  140. KOREN J, Mburu S, Trigos D, Damiani G, et al
    Generalised pustular psoriasis: the case for rare disease and orphan designation.
    Br J Dermatol. 2022 Mar 8. doi: 10.1111/bjd.21231.
    >> Share

  141. REICH K, Baraliakos X, Coates LC, Elewski B, et al
    Secukinumab demonstrates high and sustained efficacy in nail psoriasis: Post hoc analysis from phase 3 trials in patients with psoriatic arthritis.
    Br J Dermatol. 2022 Mar 8. doi: 10.1111/bjd.21233.
    >> Share

  142. XIA P, Pasquali L, Gao C, Srivastava A, et al
    miR-378a regulates keratinocyte responsiveness to IL-17A in psoriasis.
    Br J Dermatol. 2022 Mar 8. doi: 10.1111/bjd.21232.
    >> Share

  143. ZAMAGNI F, Bucchi L, Mancini S, Crocetti E, et al
    The relative contribution of the decreasing tumour thickness trend to the 2010s increase in net survival from cutaneous malignant melanoma in Italy: a population-based investigation.
    Br J Dermatol. 2022 Mar 6. doi: 10.1111/bjd.21051.
    >> Share

  144. NOVAK N, Cabanillas B
    Herpesvirus, serious and opportunistic infections associated with atopic dermatitis.
    Br J Dermatol. 2022 Mar 6. doi: 10.1111/bjd.20982.
    >> Share

  145. PARAGH G
    Epidermal melanoma prognostic factors: a link to paracrine transforming growth factor-beta signalling.
    Br J Dermatol. 2022 Mar 2. doi: 10.1111/bjd.20981.
    >> Share

  146. ZAGAR T, Hlaca N, Brajac I, Prpic-Massari L, et al
    Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccine.
    Br J Dermatol. 2022;186:e110.
    >> Share


  147. A comparison of the different questionnaires used to measure health-related quality of life in patients with dermatological conditions.
    Br J Dermatol. 2022;186:e111-e133.
    >> Share

  148. CONCHA JSS, Afarideh M, Werth VP
    Postinflammatory hyperpigmentation and erythema: new insights into the pathogenesis.
    Br J Dermatol. 2022;186:390-391.
    >> Share

  149. LAYTON AM, McDonald BS, Mohd Mustapa MF, Levell NJ, et al
    National Institute for Health and Care Excellence (NICE) acne guideline: what's the latest for dermatologists?
    Br J Dermatol. 2022;186:426-428.
    >> Share

  150. DOBOS G, Assaf C
    Transcriptomic changes during stage progression of mycosis fungoides: from translational analyses to their potential clinical implications.
    Br J Dermatol. 2022;186:387-388.
    >> Share

  151. AOKI V, Miyamoto D
    Unfolding the worldwide incidence of bullous pemphigoid: what are we missing?
    Br J Dermatol. 2022;186:386-387.
    >> Share

  152. SABROE RA, Lawlor F, Grattan CEH, Ardern-Jones MR, et al
    British Association of Dermatologists guidelines for the management of people with chronic urticaria 2021.
    Br J Dermatol. 2022;186:398-413.
    >> Share

  153. GOLDENBERG M, Amigo M, Krishna SG, Milani-Nejad N, et al
    Validation of generalized drug-related rash diagnoses using International Classification of Diseases 9th and 10th Revision codes.
    Br J Dermatol. 2022;186:583-585.
    >> Share

  154. TISACK A, Fotouhi A, Fidai C, Friedman BJ, et al
    Response to 'A clinical and biological review of keratoacanthoma': reply from authors.
    Br J Dermatol. 2022;186:592-593.
    >> Share

  155. MAZZONI D, Muir J
    Considerations in the management of keratoacanthoma.
    Br J Dermatol. 2022;186:592.
    >> Share

  156. SIMPSON K, Low ZM, Yap T, Kern JS, et al
    Ultralow-dose rituximab in pemphigus: a single-centre experience.
    Br J Dermatol. 2022;186:581-583.
    >> Share

  157. VELLAICHAMY G, Kohli I, Zubair R, Yin C, et al
    An in vivo model of postinflammatory hyperpigmentation and erythema: clinical, colorimetric and molecular characteristics.
    Br J Dermatol. 2022;186:508-519.
    >> Share

  158. BAILEY AMJ, Li HO, Burns K, Cheng W, et al
    Targeting the opioid pathway for the treatment of chronic kidney disease-associated pruritus: a systematic review and meta-analysis of randomized controlled trials.
    Br J Dermatol. 2022;186:575-577.
    >> Share

  159. XIAO MZX, Hennessey D, Iyer A, O'Keefe S, et al
    Transcriptomic changes during stage progression of mycosis fungoides.
    Br J Dermatol. 2022;186:520-531.
    >> Share

  160. PERSSON MSM, Begum N, Grainge MJ, Harman KE, et al
    The global incidence of bullous pemphigoid: a systematic review and meta-analysis.
    Br J Dermatol. 2022;186:414-425.
    >> Share

    February 2022
  161. LEE A, Stanley G, Gardiner MD, Batchelor JM, et al
    An international clinician survey CompAring Non-Absorbable Versus Absorbable sutures for Skin surgery: the CANVAS Study.
    Br J Dermatol. 2022 Feb 22. doi: 10.1111/bjd.21062.
    >> Share

  162. NAVRAZHINA K, Frew JW, Grand D, Williams SC, et al
    IL-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum.
    Br J Dermatol. 2022 Feb 22. doi: 10.1111/bjd.21060.
    >> Share

  163. MIRALI S, Fabusiwa K, Linos E
    Safety in numbers: risankizumab for moderate-to-severe psoriasis.
    Br J Dermatol. 2022 Feb 20. doi: 10.1111/bjd.20947.
    >> Share

  164. NGUYEN R
    Ocular conjunctivitis in biological therapies for atopic dermatitis.
    Br J Dermatol. 2022 Feb 16. doi: 10.1111/bjd.20945.
    >> Share

  165. HAN J, O'Neal S, Gravely A, Gupta R, et al
    Patients' attitudes towards active surveillance for basal cell carcinoma.
    Br J Dermatol. 2022 Feb 15. doi: 10.1111/bjd.21058.
    >> Share

  166. TANNENBAUM R, Strunk A, Garg A
    Age- and Sex- Adjusted Prevalence Estimates Among Pediatric Patients with Psoriasis in the United States.
    Br J Dermatol. 2022 Feb 14. doi: 10.1111/bjd.21057.
    >> Share

  167. VERMEER MH, Moins-Teisserenc H, Bagot M, Quaglino P, et al
    Flow cytometry for the assessment of blood tumour burden in cutaneous T-cell lymphoma: towards a standardised approach.
    Br J Dermatol. 2022 Feb 14. doi: 10.1111/bjd.21053.
    >> Share

  168. VAN COILE L, Verhaeghe E, Ongenae K, Brochez L, et al
    Basal cell carcinoma in older adults: how to decide when active surveillance or watchful waiting are appropriate?
    Br J Dermatol. 2022 Feb 14. doi: 10.1111/bjd.21056.
    >> Share

  169. YEN H, Huang CH, Huang IH, Hung WK, et al
    Systematic review and critical appraisal of psoriasis clinical practice guidelines: a Global Guidelines in Dermatology Mapping Project (GUIDEMAP).
    Br J Dermatol. 2022 Feb 13. doi: 10.1111/bjd.21047.
    >> Share

  170. SANGERS TE, Wakkee M, Kramer-Noels EC, Nijsten T, et al
    Limited impact of COVID-19 related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumor characteristics: A nationwide pathology registry analysis.
    Br J Dermatol. 2022 Feb 10. doi: 10.1111/bjd.21050.
    >> Share

  171. MASTORINO L, Roccuzzo G, Dapavo P, Siliquini N, et al
    Patients with psoriasis resistant to multiple biologic therapies: characteristics and definition of a difficult-to-treat population.
    Br J Dermatol. 2022 Feb 10. doi: 10.1111/bjd.21048.
    >> Share

  172. EDEN M, Hainsworth R, Gordon LG, Epton T, et al
    Cost-effectiveness of a policy-based intervention to reduce melanoma and other skin cancers associated with indoor tanning.
    Br J Dermatol. 2022 Feb 10. doi: 10.1111/bjd.21046.
    >> Share

  173. FUTAMURA M
    Easy assessment tool for disease severity of atopic dermatitis in clinical practice.
    Br J Dermatol. 2022 Feb 6. doi: 10.1111/bjd.20951.
    >> Share

  174. MARGOLIS DJ
    Atopic dermatitis: filaggrin and skin barrier dysfunction.
    Br J Dermatol. 2022 Feb 6. doi: 10.1111/bjd.20946.
    >> Share

  175. BECHMAN K, Cook ES, Dand N, Yiu ZZN, et al
    Vaccine hesitancy and access to psoriasis care in the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey.
    Br J Dermatol. 2022 Feb 1. doi: 10.1111/bjd.21042.
    >> Share

  176. GAO JM, Goiriz R, Rajpopat S, Goldsmith P, et al
    Occupational dermatoses during the second wave of the COVID-19 pandemic: a UK prospective study of 805 healthcare workers.
    Br J Dermatol. 2022;186:374-376.
    >> Share


  177. Different ways of estimating the amount of individual sun exposure.
    Br J Dermatol. 2022;186:e84-e109.
    >> Share

  178. LEIENDECKER L, Jung PS, Obenauf AC
    Targeting CD56 with an antibody-drug conjugate in Merkel cell carcinoma.
    Br J Dermatol. 2022;186:209-210.
    >> Share

  179. SCHELL SL, Nelson AM
    Are antimicrobial peptides a double-edged sword in hidradenitis suppurativa pathophysiology?
    Br J Dermatol. 2022;186:204-205.
    >> Share

  180. SINCLAIR R
    Alopecia areata: progress, but who pays?
    Br J Dermatol. 2022;186:206-207.
    >> Share

  181. VAN DER ZEE HH, van de Bunte M, van Straalen KR
    Management of mild hidradenitis suppurativa: our greatest challenge yet.
    Br J Dermatol. 2022;186:355-356.
    >> Share

  182. GLEESON D, Cliff S, Das M
    Eruptive keratoacanthomas associated with dupilumab therapy.
    Br J Dermatol. 2022;186:376-377.
    >> Share

  183. NAGOBA BS, Rayate AS, Patil NR, Gavkare AM, et al
    Citric acid treatment of infected venous eczema refractory to conventional treatment: a novel approach.
    Br J Dermatol. 2022;186:377-379.
    >> Share

  184. LEUS AJG, Horvath B, Terra JB, Diercks GFH, et al
    Eligibility criteria for programmed death receptor 1 inhibitors vs. real-world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck.
    Br J Dermatol. 2022;186:371-372.
    >> Share

  185. GAUDIN O, Milpied B, Papouin B, Hue S, et al
    Lupus erythematosus and epidermal necrolysis: a case series of 16 patients.
    Br J Dermatol. 2022;186:372-374.
    >> Share

  186. CARTER C, Martin K, Gordon C, Goulding JMR, et al
    Exploring the lived experience of women with rosacea: visible difference and psychological impact.
    Br J Dermatol. 2022;186:366-367.
    >> Share

  187. ESNAULT C, Leblond V, Martin C, Desgranges A, et al
    Adcitmer((R)) , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma.
    Br J Dermatol. 2022;186:295-306.
    >> Share

  188. FALKENHAIN-LOPEZ D, Fulgencio-Barbarin J, Puerta-Pena M, Montero-Menarguez J, et al
    Single-centre experience of using pegylated liposomal doxorubicin as maintenance treatment in mycosis fungoides.
    Br J Dermatol. 2022;186:363-365.
    >> Share

  189. HASANAJ A, Zaki F, Harman KE, Grindlay D, et al
    Cause-specific mortality in people with bullous pemphigoid and pemphigus vulgaris: a systematic review and meta-analysis.
    Br J Dermatol. 2022;186:359-361.
    >> Share

  190. YAO Y, Frew JW, Thomsen SF, Ring HC, et al
    Antimicrobial peptides in hidradenitis suppurativa: a systematic review.
    Br J Dermatol. 2022;186:236-244.
    >> Share

  191. SOUEID L, Triguero-Mas M, Dalmau A, Barrera-Gomez J, et al
    Estimating personal solar ultraviolet radiation exposure through time spent outdoors, ambient levels and modelling approaches.
    Br J Dermatol. 2022;186:266-273.
    >> Share

  192. HARRIES M, Macbeth AE, Holmes S, Chiu WS, et al
    The epidemiology of alopecia areata: a population-based cohort study in UK primary care.
    Br J Dermatol. 2022;186:257-265.
    >> Share

    January 2022
  193. PAKHCHANIAN H, Raiker R, Wolf M, Trotter SC, et al
    Examining the Risk of Breakthrough Infection and COVID-19 Vaccination Safety in Atopic Dermatitis Patients.
    Br J Dermatol. 2022 Jan 27. doi: 10.1111/bjd.21038.
    >> Share

  194. LAM M, Monaghan C, Chan AW, Drucker AM, et al
    Characterization of discontinuation and nonpublication of phase 3 randomized clinical trials for psoriasis.
    Br J Dermatol. 2022 Jan 21. doi: 10.1111/bjd.21025.
    >> Share

  195. GEALE K, Schmitt-Egenolf M
    Severity of psoriasis - Time to disentangle severity from symptom control.
    Br J Dermatol. 2022 Jan 19. doi: 10.1111/bjd.21023.
    >> Share

  196. PENNY CL, Quow K, Rundle CW, Al-Rohil RN, et al
    Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin.
    Br J Dermatol. 2022 Jan 19. doi: 10.1111/bjd.21022.
    >> Share

  197. WEI X, Wu D, Chen Y, Li H, et al
    Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
    Br J Dermatol. 2022 Jan 18. doi: 10.1111/bjd.21026.
    >> Share

  198. MUFTIN Z, Gilbert P, Thompson AR
    A Randomised Controlled Feasibility Trial of Online Compassion-focused Self-Help for Psoriasis.
    Br J Dermatol. 2022 Jan 18. doi: 10.1111/bjd.21020.
    >> Share

  199. KOZERA E, Stewart T, Gill K, De La Vega MA, et al
    Dupilumab Associated Head and Neck Dermatitis is Associated with Elevated Pre-Treatment Serum Malassezia-Specific Immunoglobulin E: A Multicenter, Prospective Cohort Study.
    Br J Dermatol. 2022 Jan 18. doi: 10.1111/bjd.21019.
    >> Share

  200. YOSIPOVITCH G, Papp K, Forman S, Han G, et al
    The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase 3 trials.
    Br J Dermatol. 2022 Jan 18. doi: 10.1111/bjd.21015.
    >> Share

  201. SCHUT C, Dalgard FJ, Bewley A, Evers AWM, et al
    Body dysmorphia in common skin diseases: Results of an observational, cross-sectional multi-centre study among dermatological out-patients in 17 European countries.
    Br J Dermatol. 2022 Jan 18. doi: 10.1111/bjd.21021.
    >> Share

  202. SORENSEN ST, Nagy D, Lindahl LM, Farkas DK, et al
    Risk of Cancer in Patients with Psoriasis and Venous Thromboembolism: a Danish Population-based Cohort study 1996-2018.
    Br J Dermatol. 2022 Jan 18. doi: 10.1111/bjd.21016.
    >> Share

  203. SEMSARIAN CR, Ma T, Nickel B, Scolyer RA, et al
    Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?
    Br J Dermatol. 2022 Jan 10. doi: 10.1111/bjd.21010.
    >> Share

  204. HALLE A, De Becdelievre A, Funalot B, Labreze C, et al
    SCN10A variants associated with congenital Harlequin Syndrome.
    Br J Dermatol. 2022 Jan 10. doi: 10.1111/bjd.21011.
    >> Share

  205. KODAMA S, Gupta D, Sullivan E, Rosenwasser N, et al
    Paradoxical psoriasis after exposure to tumor necrosis factor inhibitors in children-A retrospective cohort study.
    Br J Dermatol. 2022 Jan 7. doi: 10.1111/bjd.20980.
    >> Share

  206. KEZIC S, McAleer MA, Jakasa I, Goorden SMI, et al
    Children with atopic dermatitis show increased activity of beta- glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to local cytokine milieu.
    Br J Dermatol. 2022 Jan 7. doi: 10.1111/bjd.20979.
    >> Share

  207. SAMUELOV L, Sarig O, Malovitski K, Bergson S, et al
    Neonatal inflammatory skin and bowel disease type 1 caused by a complex genetic defect and responsive to combined anti-TNF-alpha and IL-12/23 blockade.
    Br J Dermatol. 2022 Jan 6. doi: 10.1111/bjd.20978.
    >> Share

  208. GINDL A, Schotta AM, Berent S, Markowicz M, et al
    Persistent Lyme disease with cutaneous borrelia biofilm formation.
    Br J Dermatol. 2022 Jan 6. doi: 10.1111/bjd.20977.
    >> Share

  209. CALABRESE L, Fiocco Z, Satoh TK, Peris K, et al
    Therapeutic potential of targeting IL-1 family cytokines in chronic inflammatory skin diseases.
    Br J Dermatol. 2022 Jan 6. doi: 10.1111/bjd.20975.
    >> Share

  210. KEMPF W, Petrella T, Willemze R, Jansen P, et al
    Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T-cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations - Results of an EORTC Cutaneous Lymphoma Group Workshop.
    Br J Dermatol. 2022 Jan 5. doi: 10.1111/bjd.20973.
    >> Share

  211. ARENTS BWM, Zuuren EJV, Vermeulen S, Schoones JW, et al
    Global Guidelines in Dermatology Mapping Project (GUIDEMAP) - a systematic review of atopic dermatitis clinical practice guidelines: are they clear, unbiased, trustworthy and evidence based (CUTE)?
    Br J Dermatol. 2022 Jan 4. doi: 10.1111/bjd.20972.
    >> Share

  212. ORMOND M, McParland H, Thakrar P, Donaldson A, et al
    Validation of an Oral Disease Severity Score for use in oral lichen planus.
    Br J Dermatol. 2022 Jan 4. doi: 10.1111/bjd.20968.
    >> Share

  213. AUGUSTIN M, Reich K, Yamauchi P, Pinter A, et al
    Secukinumab dosing every two weeks demonstrated superior efficacy compared with dosing every four weeks in patients with psoriasis weighing 90 kg or more: Results of a randomised controlled trial.
    Br J Dermatol. 2022 Jan 4. doi: 10.1111/bjd.20971.
    >> Share

  214. LOFVENDAHL S, Norlin JM, Schmitt-Egenolf M
    Prevalence and incidence of generalised pustular psoriasis in Sweden - a population-based register study.
    Br J Dermatol. 2022 Jan 2. doi: 10.1111/bjd.20966.
    >> Share

  215. MAGIN PJ, Tng ETV
    Specialists and generalists in skin disease management: educational, clinical and research imperatives.
    Br J Dermatol. 2022;186:1-2.
    >> Share

  216. BLANCHARD G, Guenova E
    Mogamulizumab-associated rash (MAR) mars its efficacy in the treatment of cutaneous lymphoma.
    Br J Dermatol. 2022;186:15-16.
    >> Share


  217. Psoriasis: From Gene to Clinic, 9(th) International Congress The Queen Elizabeth II Conference Centre, London, UK 9(th) -11(th) December 2021.
    Br J Dermatol. 2022;186:e2-e82.
    >> Share

  218. NATSUGA K
    Prevention of chemotherapy-induced hair loss by peroxisome proliferator-activated receptor-gamma modulation.
    Br J Dermatol. 2022;186:14-15.
    >> Share

  219. EZZEDINE K, Pandya AG
    British Association of Dermatologist guidelines: a lighthouse to help guide clinicians and researchers planning future clinical trials for vitiligo.
    Br J Dermatol. 2022;186:3-4.
    >> Share

  220. FLEMING P
    Risankizumab vs. fumaric acid esters: a direct comparison.
    Br J Dermatol. 2022;186:4-5.
    >> Share

  221. VAN STRAALEN KR, Gulliver W
    The expected missing heritability of hidradenitis suppurativa in perspective.
    Br J Dermatol. 2022;186:9-10.
    >> Share

  222. HUGHES M, Denton CP
    The critical need for patient-reported outcome measures to assess the severity and impact of systemic sclerosis.
    Br J Dermatol. 2022;186:11-12.
    >> Share

  223. GABES M
    The 'Chronic Itch Burden Scale': giving patients with chronic pruritus a voice.
    Br J Dermatol. 2022;186:10-11.
    >> Share

  224. ABBAS LF, Joseph AK, Prasad S, Zhu JL, et al
    Revealing novel, latent subsets of patients with morphoea through principal component analysis.
    Br J Dermatol. 2022;186:193-195.
    >> Share

  225. JABBOUR AJ, van Straalen KR, Colvin A, Prens EP, et al
    Clinical translation of hidradenitis suppurativa genetic studies requires global collaboration.
    Br J Dermatol. 2022;186:183-185.
    >> Share

  226. RAYINDA T, McSweeney SM, Dand N, Fenton DA, et al
    Clinical characteristics of male frontal fibrosing alopecia: a single-centre case series from London, UK.
    Br J Dermatol. 2022;186:195-197.
    >> Share

  227. SIBEONI J, Dunogue B, Dupont A, Haiddar D, et al
    Development and validation of a patient-reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale.
    Br J Dermatol. 2022;186:96-105.
    >> Share

  228. KJAERSGAARD ANDERSEN R, Clemmensen SB, Larsen LA, Hjelmborg JVB, et al
    Evidence of gene-gene interaction in hidradenitis suppurativa: a nationwide registry study of Danish twins.
    Br J Dermatol. 2022;186:78-85.
    >> Share

  229. ELEFTHERIADOU V, Atkar R, Batchelor J, McDonald B, et al
    British Association of Dermatologists guidelines for the management of people with vitiligo 2021.
    Br J Dermatol. 2022;186:18-29.
    >> Share

  230. THEUNIS J, Nordon C, Falissard B, Orri M, et al
    Development and preliminary validation of the patient-reported Chronic Itch Burden Scale assessing health-related quality of life in chronic pruritus.
    Br J Dermatol. 2022;186:86-95.
    >> Share

    December 2021
  231. MICEVIC G, Lo SN, Rajan N
    Targeting the neonatal Fc receptor in pemphigus: safety first.
    Br J Dermatol. 2021 Dec 27. doi: 10.1111/bjd.20939.
    >> Share

  232. KAPPELIN J, Green AC, Ingvar A, Ahnlide I, et al
    Incidence and trends of basal cell carcinoma in Sweden: A population-based registry study.
    Br J Dermatol. 2021 Dec 23. doi: 10.1111/bjd.20964.
    >> Share

  233. LOBATO-BEREZO A, Gonzalez-Farre M, Pujol RM
    Pustular frontal fibrosing alopecia: a new variant within the folliculitis decalvans and lichen planopilaris phenotypic spectrum?
    Br J Dermatol. 2021 Dec 23. doi: 10.1111/bjd.20962.
    >> Share

  234. PUIG L, Costanzo A, Munoz-Elias EJ, Jazra M, et al
    The biological basis of disease recurrence in psoriasis: a historical perspective and current models.
    Br J Dermatol. 2021 Dec 23. doi: 10.1111/bjd.20963.
    >> Share

  235. STEINBERG J, Iles MM, Lee JY, Wang X, et al
    Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts.
    Br J Dermatol. 2021 Dec 18. doi: 10.1111/bjd.20956.
    >> Share

  236. DANBY SG, Andrew PV, Kay LJ, Pinnock A, et al
    Enhancement of stratum corneum lipid structure improves skin barrier function and protects against irritation in adults with dry, eczema-prone, skin.
    Br J Dermatol. 2021 Dec 18. doi: 10.1111/bjd.20955.
    >> Share

  237. PRENS LM, Bouwman K, Troelstra LD, Prens EP, et al
    New Insights in Hidradenitis Suppurativa from a Population-based Dutch Cohort: Prevalence, Smoking Behaviour, Socioeconomic Status and Comorbidities.
    Br J Dermatol. 2021 Dec 18. doi: 10.1111/bjd.20954.
    >> Share

  238. THOMSON J, Hogan S, Leonardi-Bee J, Williams HC, et al
    Response to 'Interventions for basal cell carcinoma: abridged Cochrane systematic review and GRADE assessments': reply from the authors.
    Br J Dermatol. 2021 Dec 17. doi: 10.1111/bjd.20950.
    >> Share

  239. VINERETSKY KA, Domingo-Musibay E, Karagas MR, Lazovich D, et al
    A functional variant in the immune signalling receptor NKG2D alters skin cancer risk.
    Br J Dermatol. 2021 Dec 8. doi: 10.1111/bjd.20943.
    >> Share

  240. LUENGAS-MARTINEZ A, Paus R, Young HS
    A novel personalised treatment approach for psoriasis: anti-VEGF-A therapy.
    Br J Dermatol. 2021 Dec 8. doi: 10.1111/bjd.20940.
    >> Share

  241. VENABLES ZC, Tokez S, Hollestein LM, Mooyaart AL, et al
    Validation of Four Cutaneous Squamous Cell Carcinoma Staging Systems Using Nationwide Data.
    Br J Dermatol. 2021 Dec 3. doi: 10.1111/bjd.20909.
    >> Share

  242. GUELIMI R, Afach S, Regnaux JP, Bettuzzi T, et al
    Overlapping network meta-analyses on psoriasis systemic treatments: an overview, quantity does not make quality.
    Br J Dermatol. 2021 Dec 2. doi: 10.1111/bjd.20908.
    >> Share


  243. Do anti-psoriatic drugs work better in women than men?
    Br J Dermatol. 2021;185:e200-e213.
    >> Share

  244. WOLF P
    Systemic antipsoriatic treatment: do women respond better than men and if so, why?
    Br J Dermatol. 2021;185:1088-1089.
    >> Share

  245. KOTB I
    Evidence for the long-term efficacy and safety of guselkumab.
    Br J Dermatol. 2021;185:1087-1088.
    >> Share

  246. ORMEROD AD
    Epidemiology, comorbidities and mortality of pyoderma gangrenosum: new insights.
    Br J Dermatol. 2021;185:1089-1090.
    >> Share

  247. KINOSHITA-ISE M
    Refining the diagnosis and assessment methodology in frontal fibrosing alopecia.
    Br J Dermatol. 2021;185:1092-1093.
    >> Share

  248. LEE HY
    Bullous pemphigoid: towards personalized care.
    Br J Dermatol. 2021;185:1093-1094.
    >> Share

  249. HUFFMAN C, Cardis MA
    Image: Atypical chondrodermatitis nodularis due to in-ear headphones.
    Br J Dermatol. 2021;185:e199.
    >> Share

  250. FINLAY AY, Griffiths TW, Belmo S, Chowdhury MMU, et al
    Why we should abandon the misused descriptor 'erythema'.
    Br J Dermatol. 2021;185:1240-1241.
    >> Share

  251. NIKOLAKIS G, Kristandt A, Hauptmann M, Becker M, et al
    Efficacy of short-term intravenous clindamycin prior to oral clindamycin-rifampicin treatment in hidradenitis suppurativa: a retrospective case series.
    Br J Dermatol. 2021;185:1270-1272.
    >> Share

  252. SUN H, Lim JS, Silva CF, Maczuga SA, et al
    Insurance coverage gap for treatment of melasma compared with rosacea: it pays to be light.
    Br J Dermatol. 2021;185:1252-1254.
    >> Share

  253. WADA-IRIMADA M, Mizuashi M, Takahashi T, Tojo G, et al
    A retrospective study evaluating the outcomes of high-dose methylprednisolone pulse therapy for 483 patients with moderate-to-severe alopecia areata.
    Br J Dermatol. 2021;185:1267-1269.
    >> Share

  254. WESTPHAL D, Garzarolli M, Sergon M, Horak P, et al
    High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma.
    Br J Dermatol. 2021;185:1186-1199.
    >> Share

  255. DOOLAN BJ, Onoufriadis A, Kantaputra P, McGrath JA, et al
    WNT10A, dermatology and dentistry.
    Br J Dermatol. 2021;185:1105-1111.
    >> Share

  256. THOMPSON LL, Yoon J, Chang MS, Polyakov NJ, et al
    Advanced care planning, code status and end-of-life care in patients with bullous pemphigoid.
    Br J Dermatol. 2021;185:1246-1247.
    >> Share

  257. HEBERT V, Bastos S, Drenovska K, Meijer J, et al
    International multicentre observational study to assess the efficacy and safety of a 0.5 mg kg(-1) per day starting dose of oral corticosteroids to treat bullous pemphigoid.
    Br J Dermatol. 2021;185:1232-1239.
    >> Share

  258. OLSEN EA, Harries M, Tosti A, Bergfeld W, et al
    Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG).
    Br J Dermatol. 2021;185:1221-1231.
    >> Share

  259. BEN ABDALLAH H, Bech R, Fogh K, Olesen AB, et al
    Comorbidities, mortality and survival in patients with pyoderma gangrenosum: a Danish nationwide registry-nested case-control study.
    Br J Dermatol. 2021;185:1169-1175.
    >> Share

    November 2021
  260. DEAR K, Psomadakis C, Dost S, Lalagianni N, et al
    Cutaneous manifestations of PIMS-TS: a single centre experience.
    Br J Dermatol. 2021 Nov 29. doi: 10.1111/bjd.20907.
    >> Share

  261. SINIKUMPU SP, Huilaja L
    Challenges of multidimensional atopic dermatitis.
    Br J Dermatol. 2021 Nov 24. doi: 10.1111/bjd.20874.
    >> Share

  262. DEZOTEUX F, El Mesbahi S, Tedbirt B, Grosjean J, et al
    Immunomodulatory or/and immunosuppressive drugs should not avoid skin test for the assessment of drug allergy.
    Br J Dermatol. 2021 Nov 22. doi: 10.1111/bjd.20901.
    >> Share

  263. SUN MD, Kentley J, Mehta P, Duzsa S, et al
    Accuracy of commercially available smartphone applications for the detection of melanoma.
    Br J Dermatol. 2021 Nov 22. doi: 10.1111/bjd.20903.
    >> Share

  264. CHUNG JG, Holtkamp H, Nieuwoudt M, Matthews H, et al
    The combination of Raman Spectroscopy and Mass Spectrometry to investigate cutaneous metallosis.
    Br J Dermatol. 2021 Nov 22. doi: 10.1111/bjd.20902.
    >> Share

  265. DAND N
    Genome-wide scan for structural variation underlying psoriasis.
    Br J Dermatol. 2021 Nov 22. doi: 10.1111/bjd.20836.
    >> Share

  266. CHALMERS RJG
    Recognizing psoriasis in children and adolescents: the DIPSOC study.
    Br J Dermatol. 2021 Nov 22. doi: 10.1111/bjd.20825.
    >> Share

  267. MARUSIC Z, Calonje E
    Skin adnexal tumours in a tertiary dermatopathology service.
    Br J Dermatol. 2021 Nov 15. doi: 10.1111/bjd.20816.
    >> Share

  268. BERGAMASCHI D
    Autophagy protects from photoageing in skin fibroblasts.
    Br J Dermatol. 2021 Nov 15. doi: 10.1111/bjd.20822.
    >> Share

  269. PARK JH, Yoon JE, Kim YH, Kim Y, et al
    The potential skin lightening candidate, senolytic drug ABT263, for photoageing pigmentation.
    Br J Dermatol. 2021 Nov 13. doi: 10.1111/bjd.20893.
    >> Share

  270. COSGAREA I, McConnell AT, Ewen T, Tang D, et al
    Melanoma secretion of TGFbeta-2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration.
    Br J Dermatol. 2021 Nov 13. doi: 10.1111/bjd.20889.
    >> Share

  271. DE VERE HUNT I, van Egmond S, Nava V, Khodosh R, et al
    Telehealth for Older Adults with Skin Disease: A Qualitative Exploration of Dermatologists' Experiences & Recommendations for Improving Care.
    Br J Dermatol. 2021 Nov 13. doi: 10.1111/bjd.20891.
    >> Share

  272. MARNIQUET ME, Seneschal J, Darrigade AS, Staumont-Salle D, et al
    Reasons for Discontinuation of dupilumab in Adult Atopic Dermatitis in Clinical Practice.
    Br J Dermatol. 2021 Nov 8. doi: 10.1111/bjd.20883.
    >> Share

  273. WAN J, Shin DB, Syed MN, Abuabara K, et al
    Risk of herpesvirus, serious, and opportunistic infections in atopic dermatitis: a population-based cohort study.
    Br J Dermatol. 2021 Nov 8. doi: 10.1111/bjd.20887.
    >> Share

  274. BREGNHOJ A, Thuesen KKH, Emmanuel T, Litman T, et al
    HSP90 inhibitor RGRN-305 for oral treatment of plaque type psoriasis: efficacy, safety and biomarker results in an open-label proof-of-concept study.
    Br J Dermatol. 2021 Nov 8. doi: 10.1111/bjd.20880.
    >> Share

  275. JABOURI H, Abbott RA
    Sustainability in skin cancer surgery.
    Br J Dermatol. 2021 Nov 8. doi: 10.1111/bjd.20886.
    >> Share

  276. MAZZONI D, Muir J
    Response to "Interventions for basal cell carcinoma: abridged Cochrane systematic reviews and GRADE assessments".
    Br J Dermatol. 2021 Nov 8. doi: 10.1111/bjd.20878.
    >> Share

  277. PAPP KA, Gooderham MJ, Albrecht LE, Raymond MA, et al
    Treatment satisfaction, safety, and effectiveness of adding methotrexate to adalimumab in psoriasis patients responding sub-optimally to adalimumab in a real-world setting.
    Br J Dermatol. 2021 Nov 8. doi: 10.1111/bjd.20885.
    >> Share

  278. MAEDA T, Hiura A, Uehara J, Toyoshima R, et al
    Early tumor response assessment may avoid serious immune-related adverse events in nivolumab and ipilimumab combination therapy for stage IV melanoma.
    Br J Dermatol. 2021 Nov 8. doi: 10.1111/bjd.20879.
    >> Share

  279. CHIESA Z
    How important is it to distinguish between eczema and atopic dermatitis in infants? Implications for prognosis and epidemiological research.
    Br J Dermatol. 2021 Nov 2. doi: 10.1111/bjd.20814.
    >> Share

  280. BATAILLE V, Puig S
    COVID-19 vaccines and skin manifestations.
    Br J Dermatol. 2021 Nov 2. doi: 10.1111/bjd.20807.
    >> Share

  281. BEN ABDALLAH H, Vestergaard C
    Atopic dermatitis, hypertension and cardiovascular disease.
    Br J Dermatol. 2021 Nov 2. doi: 10.1111/bjd.20802.
    >> Share

  282. CAZZANIGA S, Naldi L
    Administrative data and scientific evidence: a lesson from France - the safety of systemic treatment for psoriasis during the COVID-19 pandemic.
    Br J Dermatol. 2021 Nov 2. doi: 10.1111/bjd.20776.
    >> Share

  283. CAMARA NOS
    Do the gut and skin microbiomes share thoughts on melanoma development?
    Br J Dermatol. 2021 Nov 2. doi: 10.1111/bjd.20811.
    >> Share

  284. GAMBICHLER T, Krogias C, Tischoff I, Tannapfel A, et al
    Bilateral giant cell arteritis with skin necrosis following SARS-CoV-2 vaccination.
    Br J Dermatol. 2021 Nov 2. doi: 10.1111/bjd.20824.
    >> Share

  285. PALLER AS, Tan JKL, Bagel J, Rossi AB, et al
    IGAxBSA composite for assessing disease severity and response in patients with atopic dermatitis.
    Br J Dermatol. 2021 Nov 2. doi: 10.1111/bjd.20872.
    >> Share

  286. LAMBERT WC, Sy CB, Madari AP, Schwartz RA, et al
    Perineal cutaneous basal cell carcinomas in patients with familial seronegative celiac disease: Report of three cases.
    Br J Dermatol. 2021 Nov 2. doi: 10.1111/bjd.20870.
    >> Share

  287. SCHREUDER K, Hollestein L, Nijsten TEC, Wakkee M, et al
    A nationwide study of the incidence and trends of first and multiple basal cell carcinoma in the Netherlands and prediction of future incidence.
    Br J Dermatol. 2021 Nov 2. doi: 10.1111/bjd.20871.
    >> Share

  288. KABASHIMA K, Matsumura T, Komazaki H, Kawashima M, et al
    Nemolizumab plus topical agents in patients with atopic dermatitis and moderate-to-severe pruritus provide improvement in pruritus and signs of atopic dermatitis for up to 68 weeks: results from two phase III, long-term studies.
    Br J Dermatol. 2021 Nov 2. doi: 10.1111/bjd.20873.
    >> Share

  289. MAURUS K, Kosnopfel C, Kneitz H, Appenzeller S, et al
    Cutaneous epithelioid hemangiomas show somatic mutations in the MAPK pathway.
    Br J Dermatol. 2021 Nov 2. doi: 10.1111/bjd.20869.
    >> Share

  290. SZABO A, Brodszky V, Rencz F
    A comparative study on the measurement properties of DLQI, DLQI-R and Skindex-16.
    Br J Dermatol. 2021 Nov 1. doi: 10.1111/bjd.20765.
    >> Share


  291. Patients who misuse alcohol have poorer responses to systemic treatments for psoriasis.
    Br J Dermatol. 2021;185:e179-e198.
    >> Share

  292. HWANG E, Tomayko MM
    COVID-19 outcomes in patients with autoimmune blistering disease.
    Br J Dermatol. 2021;185:1048-1050.
    >> Share

  293. HSIAO J, Shi V
    Hidradenitis suppurativa: redirecting a life trajectory.
    Br J Dermatol. 2021;185:878.
    >> Share

  294. ADOTAMA P, Callender V, Kolla A, Young C, et al
    Comparing the clinical differences in white and black women with frontal fibrosing alopecia.
    Br J Dermatol. 2021;185:1074-1076.
    >> Share

  295. TEIXEIRA MS, Gavazzoni Dias MFR, Vilar EAG, Pantaleao L, et al
    Histopathological differential diagnosis of frontal fibrosing alopecia and fibrosing alopecia in a pattern distribution.
    Br J Dermatol. 2021;185:1069-1070.
    >> Share

  296. SINIKUMPU SP, Vahanikkila H, Jokelainen J, Tasanen K, et al
    Male patients with rosacea have increased risk for migraine: a population-based study.
    Br J Dermatol. 2021;185:1058-1061.
    >> Share

  297. PAPADAVID E, Kapniari E, Pappa V, Nikolaou V, et al
    Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sezary syndrome with variable CD30 positivity.
    Br J Dermatol. 2021;185:1035-1044.
    >> Share

  298. CHU CB, Yang CC, Tsai SJ
    Global data analysis supports smoking as the fundamental element associated with geographical sex disparities in hidradenitis suppurativa.
    Br J Dermatol. 2021;185:1054-1056.
    >> Share

  299. CROITORU D, Sibbald C, Alavi A, Brooks S, et al
    Challenging the association of hepatitis C and pyoderma gangrenosum.
    Br J Dermatol. 2021;185:1047-1048.
    >> Share

  300. MOYAL L, Arkin C, Gorovitz-Haris B, Querfeld C, et al
    Mycosis fungoides-derived exosomes promote cell motility and are enriched with microRNA-155 and microRNA-1246, and their plasma-cell-free expression may serve as a potential biomarker for disease burden.
    Br J Dermatol. 2021;185:999-1012.
    >> Share

  301. HOWELLS L, Lancaster N, McPhee M, Bundy C, et al
    Thematic synthesis of the experiences of people with hidradenitis suppurativa: a systematic review.
    Br J Dermatol. 2021;185:921-934.
    >> Share

  302. LOFVENDAHL S, Norlin JM, Schmitt-Egenolf M
    Prevalence and incidence of palmoplantar pustulosis in Sweden: a population-based register study.
    Br J Dermatol. 2021;185:945-951.
    >> Share

  303. PRENS LM, Porter ML, Savage KT, Salian P, et al
    Hidradenitis suppurativa disease course during pregnancy and postpartum: a retrospective survey study.
    Br J Dermatol. 2021;185:1072-1074.
    >> Share

    October 2021
  304. HOYER A, Rehbinder EM, Fardig M, Asad S, et al
    Filaggrin mutations in relation to skin barrier and atopic dermatitis in early infancy.
    Br J Dermatol. 2021 Oct 26. doi: 10.1111/bjd.20831.
    >> Share

  305. VAN WINDEN MEC, Klosters FM, Hamaker M, Olde Rikkert MG, et al
    Optimizing shared decision-making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic.
    Br J Dermatol. 2021 Oct 26. doi: 10.1111/bjd.20833.
    >> Share

  306. GUTERMUTH J, Pink AE, Worm M, Soldbro L, et al
    Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of cyclosporine A: a placebo-controlled, randomized, Phase 3 clinical trial (ECZTRA 7).
    Br J Dermatol. 2021 Oct 26. doi: 10.1111/bjd.20832.
    >> Share

  307. OLIVER R, Krueger JG, Glatt S, Vajjah P, et al
    Bimekizumab for the Treatment of Moderate to Severe Plaque Psoriasis: Efficacy, Safety, Pharmacokinetics, Pharmacodynamics and Transcriptomics from a Phase 2a Randomized, Multicenter Double-Blinded Study.
    Br J Dermatol. 2021 Oct 23. doi: 10.1111/bjd.20827.
    >> Share

  308. SBIDIAN E, Pina-Vegas L
    Head-to-head trials in psoriasis and psoriatic arthritis: how to conclude?
    Br J Dermatol. 2021 Oct 20. doi: 10.1111/bjd.20771.
    >> Share

  309. GORDON KB, Lebwohl M, Papp KA, Bachelez H, et al
    Long-Term Safety of Risankizumab From 17 Clinical Trials in Patients With Moderate-to-Severe Plaque Psoriasis.
    Br J Dermatol. 2021 Oct 15. doi: 10.1111/bjd.20818.
    >> Share

  310. WOLLENBERG A, Beck LA, de Bruin Weller M, Simpson EL, et al
    Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials.
    Br J Dermatol. 2021 Oct 12. doi: 10.1111/bjd.20810.
    >> Share

  311. MONNET P, Herms F, Djermane M, Dalac S, et al
    Characterization of patients with advanced basal cell carcinoma progressing while receiving Hedgehog pathway inhibitors.
    Br J Dermatol. 2021 Oct 12. doi: 10.1111/bjd.20808.
    >> Share

  312. HENDERSON BERG MH, Davison K, Popradi G
    Real-world effectiveness of brentuximab vedotin in the treatment of CD30-positive cutaneous T-cell lymphoma: A single-centre retrospective review.
    Br J Dermatol. 2021 Oct 5. doi: 10.1111/bjd.20786.
    >> Share

  313. PUELLES J, Fofana F, Rodriguez D, Silverberg JI, et al
    Psychometric Validation and Responder Definition of Sleep Disturbance Numerical Rating Scale in Moderate-To-Severe Atopic Dermatitis.
    Br J Dermatol. 2021 Oct 5. doi: 10.1111/bjd.20783.
    >> Share

  314. GOEBELER M, Bata-Csorgo Z, De Simone C, Didona B, et al
    Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase 2 multicentre, open-label feasibility trial.
    Br J Dermatol. 2021 Oct 5. doi: 10.1111/bjd.20782.
    >> Share

  315. EIGENTLER T
    Benefits of a nationwide population-based skin cancer screening programme - still a controversial debate.
    Br J Dermatol. 2021 Oct 4. doi: 10.1111/bjd.20709.
    >> Share

  316. BERMINGHAM WH, Ardern-Jones MR, Huissoon AP, Krishna MT, et al
    Forewarned is forearmed: chronic spontaneous urticaria as a potential risk to effective SARS-CoV-2 vaccine uptake and global public health.
    Br J Dermatol. 2021;185:838-839.
    >> Share

  317. MURRELL DF, Patsatsi A, Stavropoulos P, Baum S, et al
    Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study.
    Br J Dermatol. 2021;185:745-755.
    >> Share

  318. SHOURICK J, Ahmed M, Seneschal J, Passeron T, et al
    Development of a shared decision-making tool in vitiligo: an international study.
    Br J Dermatol. 2021;185:787-796.
    >> Share

  319. HAW WY, Al-Janabi A, Arents BWM, Asfour L, et al
    Global Guidelines in Dermatology Mapping Project (GUIDEMAP): a scoping review of dermatology clinical practice guidelines.
    Br J Dermatol. 2021;185:736-744.
    >> Share

    September 2021
  320. FROMME JE, Zigrino P
    Melanoma metastasis, BRAF mutation and GJB5 connexin expression: a new prognostic factor.
    Br J Dermatol. 2021 Sep 30. doi: 10.1111/bjd.20756.
    >> Share

  321. CHONG BF
    Guidance for providers on the treatment and management of cutaneous lupus erythematosus.
    Br J Dermatol. 2021 Sep 30. doi: 10.1111/bjd.20746.
    >> Share

  322. OH Y, Markova A, Noor SJ, Rotemberg V, et al
    Standardized Clinical Photography Considerations in Patients Across Skin Tones.
    Br J Dermatol. 2021 Sep 26. doi: 10.1111/bjd.20766.
    >> Share

  323. NAKAMURA T, Haider S, Fontanella S, Murray CS, et al
    Modelling trajectories of parentally reported and physician-confirmed atopic dermatitis in a birth cohort study.
    Br J Dermatol. 2021 Sep 26. doi: 10.1111/bjd.20767.
    >> Share

  324. KIM J, Choi H
    The mucin protein MUCL1 regulates melanogenesis and melanoma genes in a manner dependent on threonine content.
    Br J Dermatol. 2021 Sep 21. doi: 10.1111/bjd.20761.
    >> Share

  325. IBBOTSON SH, Ferguson J, Moseley H, Samuel IDW, et al
    A Randomised Assessor Blinded Comparison of Low Irradiance and Conventional Irradiance Photodynamic Therapy for Superficial Basal Cell Carcinoma and Bowen's Disease.
    Br J Dermatol. 2021 Sep 21. doi: 10.1111/bjd.20762.
    >> Share

  326. POSPISCHIL I, Guenova E
    Mycosis fungoides-derived exosomes and their microRNA-1246 cargo: a message from the skin.
    Br J Dermatol. 2021 Sep 14. doi: 10.1111/bjd.20695.
    >> Share

  327. ULRIKSDOTTER J, Svedman C, Bruze M, Mowitz M, et al
    Allergic contact dermatitis caused by dipropylene glycol diacrylate in the Omnipod(R) insulin pump.
    Br J Dermatol. 2021 Sep 12. doi: 10.1111/bjd.20751.
    >> Share

  328. MAEDA T, Hiura A, Uehara J, Toyoshima R, et al
    Combined carboplatin and paclitaxel therapy improves overall survival in patients with nivolumab-resistant acral and mucosal melanoma.
    Br J Dermatol. 2021 Sep 12. doi: 10.1111/bjd.20758.
    >> Share

  329. ZHEN Q, Zhang Y, Yu Y, Yang H, et al
    Three Novel Structural Variations at MHC and IL12B Predisposing to Psoriasis.
    Br J Dermatol. 2021 Sep 9. doi: 10.1111/bjd.20752.
    >> Share

  330. FORSYTH JR, Russell E, McPherson T
    A retrospective case series of paediatric Stevens-Johnson syndrome and toxic epidermal necrolysis: evaluation of practice using the British Association of Dermatology's National Guidelines for children and young people.
    Br J Dermatol. 2021 Sep 4. doi: 10.1111/bjd.20741.
    >> Share

  331. DING J, Joseph M, Yau N, Khosa F, et al
    Underreporting of race and ethnicity in pediatric atopic dermatitis clinical trials: A cross-sectional analysis of demographic reporting and representation.
    Br J Dermatol. 2021 Sep 4. doi: 10.1111/bjd.20740.
    >> Share

  332. BURDEN-THE E, Murphy R, Gran S, Nijsten T, et al
    Identifying the best predictive diagnostic criteria for psoriasis in children (<18 years): A UK multicenter case-control diagnostic accuracy study (DIPSOC study).
    Br J Dermatol. 2021 Sep 3. doi: 10.1111/bjd.20689.
    >> Share

  333. RA AG, Ho B, Bickerstaffe L, Bewley A, et al
    More than skin deep: a survey of the real-life experiences of acne vulgaris.
    Br J Dermatol. 2021 Sep 2. doi: 10.1111/bjd.20737.
    >> Share

  334. MONCRIEFF MD, Nobes JP
    Commentary on the British Association of Dermatologists UK basal cell carcinoma guidelines 2021: all together now ....
    Br J Dermatol. 2021 Sep 2. doi: 10.1111/bjd.20694.
    >> Share

  335. COTTER C, Solman L, Flohr C
    A national audit of oral propranolol for the treatment of Infantile Hemangiomas.
    Br J Dermatol. 2021 Sep 2. doi: 10.1111/bjd.20738.
    >> Share


  336. 19th Congress - European Society for Dermatology and Psychiatry (ESDaP) & 2nd Brain Skin Colloquium Conference. 11(th) - 12(th) June 2021.
    Br J Dermatol. 2021;185:e70-e156.
    >> Share

  337. HEPPT MV, Steeb T, Berking C
    Another step on the road towards standardized outcome reporting for congenital melanocytic naevi: one more to go!
    Br J Dermatol. 2021 Sep 1. doi: 10.1111/bjd.20691.
    >> Share

  338. MISERY L
    Development of tools for the evaluation of pruritus.
    Br J Dermatol. 2021;185:478-479.
    >> Share

  339. WOLFE C, Rudd E, Ng J, Weir J, et al
    An unusual dermoscopic appearance of scabies.
    Br J Dermatol. 2021;185:e69.
    >> Share

  340. BARBIERI JS, Drucker AM
    The need for comparative effectiveness data to guide management of acne vulgaris.
    Br J Dermatol. 2021;185:476-477.
    >> Share

  341. ALZAHRANI N, Grossman-Kranseler J, Swali R, Fiumara K, et al
    Hailey-Hailey disease treated with dupilumab: a case series.
    Br J Dermatol. 2021;185:680-682.
    >> Share

  342. KOMATSU-FUJII T, Murata T, Adachi E, Kaku Y, et al
    Sterile abscesses possibly stem from acantholytic folliculitis in comedonal Darier disease: a case report.
    Br J Dermatol. 2021;185:667-669.
    >> Share

  343. KERKEMEYER KLS, Sinclair RD, Bhoyrul B
    Topical tofacitinib for the treatment of alopecia areata affecting facial hair.
    Br J Dermatol. 2021;185:677-679.
    >> Share

  344. HACARD F, Giraudeau B, d'Acremont G, Jegou MH, et al
    Guidelines for the management of chronic spontaneous urticaria: recommendations supported by the Centre of Evidence of the French Society of Dermatology.
    Br J Dermatol. 2021;185:658-660.
    >> Share

  345. DIJKSTRA DJ, Liem SIE, van Leeuwen NM, Fehres CM, et al
    Anti-C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single-centre, cross-sectional study.
    Br J Dermatol. 2021;185:657-658.
    >> Share

  346. ABEL MK, Jelousi S, Berger T, Murase JE, et al
    Immunological eruptions of ageing: reframing chronic pruritic rashes in older adults.
    Br J Dermatol. 2021;185:638-639.
    >> Share

  347. LALLAS A, Moscarella E, Kittler H, Longo C, et al
    Real-world experience of off-label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna.
    Br J Dermatol. 2021;185:675-677.
    >> Share

  348. LINGGONEGORO DW, Song H, Jones KM, Lee PY, et al
    Familial chilblain lupus in a child with heterozygous mutation in SAMHD1 and normal interferon signature.
    Br J Dermatol. 2021;185:650-652.
    >> Share

  349. TISACK A, Fotouhi A, Fidai C, Friedman BJ, et al
    A clinical and biological review of keratoacanthoma.
    Br J Dermatol. 2021;185:487-498.
    >> Share

  350. STUART B, Maund E, Wilcox C, Sridharan K, et al
    Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis.
    Br J Dermatol. 2021;185:512-525.
    >> Share

  351. LAUFER BRITVA R, Keren A, Ginzburg A, Ullmann Y, et al
    Evidence from a humanized mouse model of androgenetic alopecia that platelet-rich plasma stimulates hair regrowth, hair shaft diameter and vellus-to-terminal hair reconversion in vivo.
    Br J Dermatol. 2021;185:644-646.
    >> Share

  352. FREW JW
    Differential profiles of gamma secretase Notch signalling in hidradenitis suppurativa: the need for genotype-endotype-phenotype analysis.
    Br J Dermatol. 2021;185:636-637.
    >> Share

    August 2021
  353. GONZALEZ JM, Reed SD, Johnson FR
    Stratified psoriasis treatment plans: why is patient preference information needed?
    Br J Dermatol. 2021 Aug 31. doi: 10.1111/bjd.20697.
    >> Share

  354. BORTOLUZZI P, Ferrucci S, Galimberti D, Garavelli F, et al
    New insights on ocular surface disease in atopic dermatitis patients treated with dupilumab.
    Br J Dermatol. 2021 Aug 25. doi: 10.1111/bjd.20706.
    >> Share

  355. TRUM NA, Zain J, Martinez XU, Parekh V, et al
    Mogamulizumab Efficacy is Underscored by its Associated Rash that Mimics Cutaneous T-cell Lymphoma: A Retrospective Single-Centre Case Series.
    Br J Dermatol. 2021 Aug 24. doi: 10.1111/bjd.20708.
    >> Share

  356. LANGTON AK, Watson REB
    Identification of novel skin ageing genes: evidence from across the pigmentary continuum.
    Br J Dermatol. 2021 Aug 18. doi: 10.1111/bjd.20636.
    >> Share

  357. CUST AE
    Strengthening melanoma prevention and early detection among people with type 2 diabetes.
    Br J Dermatol. 2021 Aug 18. doi: 10.1111/bjd.20633.
    >> Share

  358. STANDL M
    Addressing the causality of the association of atopic dermatitis with depression and anxiety using Mendelian randomization.
    Br J Dermatol. 2021 Aug 17. doi: 10.1111/bjd.20622.
    >> Share

  359. VAN DE KERKHOF PCM
    The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis.
    Br J Dermatol. 2021 Aug 17. doi: 10.1111/bjd.20624.
    >> Share

  360. COOK S, Bajwa D, Hollestein L, Husain A, et al
    A 5-year retrospective review of skin adnexal tumours received at a tertiary dermatopathology service: Implications for linked genetic diagnoses.
    Br J Dermatol. 2021 Aug 13. doi: 10.1111/bjd.20701.
    >> Share

  361. WAN J, Abuabara K
    Growing evidence for an association between inflammatory skin disease and chronic kidney disease.
    Br J Dermatol. 2021 Aug 11. doi: 10.1111/bjd.20632.
    >> Share

  362. JACOBY TV, Chang MS, Thompson LL, Foreman RK, et al
    Histopathologically-confirmed lichenoid eruptions from immune checkpoint inhibitor therapy: A retrospective cohort analysis.
    Br J Dermatol. 2021 Aug 10. doi: 10.1111/bjd.20698.
    >> Share

  363. ZHAO Y, Wu L, Lu Q, Gao X, et al
    The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study.
    Br J Dermatol. 2021 Aug 6. doi: 10.1111/bjd.20690.
    >> Share

  364. DE BRITO M, Stevens BR, Yiu ZZN
    Can artificial intelligence be used for accurate remote scoring of the Psoriasis Area and Severity Index (PASI) in adult patients with plaque psoriasis? A Critically Appraised Topic.
    Br J Dermatol. 2021 Aug 5. doi: 10.1111/bjd.20663.
    >> Share

  365. SIL A, Panigrahi A, Pramanik JD
    Isolated cutaneous larva migrans over the scalp in a hod carrier.
    Br J Dermatol. 2021 Aug 3. doi: 10.1111/bjd.20589.
    >> Share

  366. VAN DER SCHOOT LS, van den Reek JMPA
    Data-driven prediction of biologic treatment responses in psoriasis: steps towards precision medicine.
    Br J Dermatol. 2021 Aug 1. doi: 10.1111/bjd.20625.
    >> Share

  367. CARBALLIDO VAZQUEZ AM, Morgado B
    Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination.
    Br J Dermatol. 2021;185:e34.
    >> Share

  368. TSAO H
    Melanoma medicine in the new millennium.
    Br J Dermatol. 2021;185:239-240.
    >> Share


  369. Does fludarabine have a beneficial effect in recessive dystrophic epidermolysis bullosa?
    Br J Dermatol. 2021;185:e36-e67.
    >> Share

  370. HODAK E
    Is lymph node core-needle biopsy an alternative to excisional biopsy for the accurate staging of mycosis fungoides/Sezary syndrome and predicting the survival of patients?
    Br J Dermatol. 2021;185:251-252.
    >> Share

  371. ORTIZ-ROMERO PL
    The time for new biomarkers in mycosis fungoides/Sezary syndrome is here.
    Br J Dermatol. 2021;185:250-251.
    >> Share

  372. PURVIS CG, Emmerich VK, Feldman SR
    Tildrakizumab: interpreting the data.
    Br J Dermatol. 2021;185:242-243.
    >> Share

  373. CHRETIEN B, Dolladille C, Alexandre J, Fedrizzi S, et al
    Dupilumab-associated arthralgia: an observational retrospective study in VigiBase((R)).
    Br J Dermatol. 2021;185:464-465.
    >> Share

  374. LI X, Qian H, Natsuaki Y, Koga H, et al
    Clinical and immunological findings in 55 patients with anti-laminin 332-type mucous membrane pemphigoid.
    Br J Dermatol. 2021;185:449-451.
    >> Share

  375. PAN C, Humbatova A, Zheng L, Cesarato N, et al
    Additional causal SNRPE mutations in hereditary hypotrichosis simplex.
    Br J Dermatol. 2021;185:439-441.
    >> Share

  376. OTTEVANGER R, de Bruin DT, Willemze R, Jansen PM, et al
    Incidence of mycosis fungoides and Sezary syndrome in the Netherlands between 2000 and 2020.
    Br J Dermatol. 2021;185:434-435.
    >> Share

  377. ABELS C, Soeberdt M, Kilic A, Reich H, et al
    A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial.
    Br J Dermatol. 2021;185:315-322.
    >> Share

  378. CALVANI J, de Masson A, de Margerie-Mellon C, de Kerviler E, et al
    Image-guided lymph node core-needle biopsy predicts survival in mycosis fungoides and Sezary syndrome.
    Br J Dermatol. 2021;185:419-427.
    >> Share

  379. VANDEN OEVER M, Muldoon D, Mathews W, Tolar J, et al
    Fludarabine modulates expression of type VII collagen during haematopoietic stem cell transplantation for recessive dystrophic epidermolysis bullosa.
    Br J Dermatol. 2021;185:380-390.
    >> Share

  380. DOBOS G, De Cevins C, Ly Ka So S, Jean-Louis F, et al
    The value of five blood markers in differentiating mycosis fungoides and Sezary syndrome: a validation cohort.
    Br J Dermatol. 2021;185:405-411.
    >> Share

    July 2021
  381. XIE H, Zhou L, Liu F, Long J, et al
    Autophagy induction regulates aquaporin 3-mediated skin fibroblasts aging.
    Br J Dermatol. 2021 Jul 28. doi: 10.1111/bjd.20662.
    >> Share

  382. YOUSAF M, Ayasse M, Ahmed A, Gwillim E, et al
    Association between Atopic Dermatitis and Hypertension: A Systematic Review and Meta-Analysis.
    Br J Dermatol. 2021 Jul 28. doi: 10.1111/bjd.20661.
    >> Share

  383. PENSO L, Dray-Spira R, Weill A, Zureik M, et al
    Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1,326,312 patients in France.
    Br J Dermatol. 2021 Jul 26. doi: 10.1111/bjd.20659.
    >> Share

  384. DATZMANN T, Schoffer O, Meier F, Seidler A, et al
    Patients benefit from participating in the German skin cancer screening program? A large cohort study based on administrative data.
    Br J Dermatol. 2021 Jul 21. doi: 10.1111/bjd.20658.
    >> Share

  385. GONDO GC, Merola JF, Bell S, Blauvelt A, et al
    Decreased quality of life in people with psoriasis and psoriatic arthritis versus people with psoriasis alone: data from a national US survey.
    Br J Dermatol. 2021 Jul 21. doi: 10.1111/bjd.20657.
    >> Share

  386. SAEKI H, Baba N, Ito K, Yokota D, et al
    Difamilast ointment, a selective phosphodiesterase 4 inhibitor, in paediatric patients with atopic dermatitis: A phase 3 randomised double-blind, vehicle-controlled trial.
    Br J Dermatol. 2021 Jul 21. doi: 10.1111/bjd.20655.
    >> Share

  387. WHITE JML, Lui H, Chute CG, Jakob R, et al
    The WHO ICD-11 Classification of Dermatological Disorders: a new comprehensive online skin disease taxonomy designed by and for dermatologists.
    Br J Dermatol. 2021 Jul 21. doi: 10.1111/bjd.20656.
    >> Share

  388. PROCOPIO-AZEVEDO AC, Rabello VBS, Muniz MM, Figueiredo-Carvalho MHG, et al
    Hypersensitivity reactions in sporotrichosis: A retrospective cohort of 325 patients from a reference hospital in Rio de Janeiro, Brazil (2005-2018).
    Br J Dermatol. 2021 Jul 14. doi: 10.1111/bjd.20646.
    >> Share

  389. AFRA TP, Siraj MM, Razmi T M
    Response to 'COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations': reply from authors.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20638.
    >> Share

  390. STOER NC, Botteri E, Busund M, Ghiasvand R, et al
    Menopausal hormone therapy and risk of melanoma: a population-based cohort study.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20640.
    >> Share

  391. VURAL S, Kerl K, Dogan PE, Vollmer S, et al
    Lesional activation of Tc 17 cells in Behcet's disease and psoriasis supports HLA-class I-mediated autoimmune responses.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20643.
    >> Share

  392. NAVRAZHINA K, Renert-Yuval Y, Frew JW, Grand D, et al
    Large-scale serum analysis identifies unique systemic biomarkers in psoriasis and hidradenitis suppurativa.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20642.
    >> Share

  393. CATALA A, Munoz-Santos C, Galvan-Casas C, Roncero Riesco M, et al
    Cutaneous reactions after SARS-COV-2 vaccination: A cross-sectional Spanish nationwide study of 405 cases.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20639.
    >> Share

  394. SCATOLINI M, Patel A, Grosso E, Mello-Grand M, et al
    GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma.
    Br J Dermatol. 2021 Jul 8. doi: 10.1111/bjd.20629.
    >> Share

  395. SCHNEIDER AM, Nelson AM
    Food for thought: does host diet affect skin microbes?
    Br J Dermatol. 2021 Jul 8. doi: 10.1111/bjd.20573.
    >> Share

  396. GAMBICHLER T, Boms S, Hessam S, Tischoff I, et al
    Primary cutaneous anaplastic large cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination.
    Br J Dermatol. 2021 Jul 6. doi: 10.1111/bjd.20630.
    >> Share

  397. PATHMARAJAH P, Gkini MA, Fox H, Muralidharan V, et al
    Patients with nodular prurigo commonly have pre-existing psychological disease which requires treatment concomitant with cutaneous treatments.
    Br J Dermatol. 2021 Jul 6. doi: 10.1111/bjd.20627.
    >> Share

  398. VITALI F, Colucci R, Di Paola M, Pindo M, et al
    Early melanoma invasivity correlates with gut fungal and bacterial profiles.
    Br J Dermatol. 2021 Jul 6. doi: 10.1111/bjd.20626.
    >> Share

  399. HOLLESTEIN LM, Arnspang Pedersen S
    Increased cutaneous squamous cell carcinoma risk with hydrochlorothiazide use: is there a safe alternative?
    Br J Dermatol. 2021 Jul 5. doi: 10.1111/bjd.20526.
    >> Share

  400. CHEN CB, Chung WH
    Current agreement on the management of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Br J Dermatol. 2021 Jul 5. doi: 10.1111/bjd.20515.
    >> Share

  401. VOLC-PLATZER B
    Fumaric acid esters for paediatric psoriasis.
    Br J Dermatol. 2021;185:5-6.
    >> Share


  402. Ceramide kinase-like protein promotes cutaneous squamous cell carcinoma.
    Br J Dermatol. 2021;185:e4-e33.
    >> Share

  403. NIJSTEN T, Silverberg J, Gisondi P, Vestergaard C, et al
    Considerations in association studies in dermatoepidemiology.
    Br J Dermatol. 2021;185:1-2.
    >> Share

  404. HAMBLY R, Kirby B
    Biologic survival in hidradenitis suppurativa: much done, more to do.
    Br J Dermatol. 2021;185:16-17.
    >> Share

  405. MURRELL DF, Paul CF
    What instruments should we add to our toolbox for measuring the severity and control of eczema?
    Br J Dermatol. 2021;185:13-14.
    >> Share

  406. GIAMARELLOS-BOURBOULIS EJ
    Neutrophil trafficking: the missing link in the pathogenesis of hidradenitis suppurativa.
    Br J Dermatol. 2021;185:15-16.
    >> Share

  407. MAHMOUDI H, Nili A, Salehi Farid A, Tavakolpour S, et al
    Paradoxical worsening of pemphigus after rituximab presenting as figurate bullous eruption.
    Br J Dermatol. 2021;185:e2.
    >> Share

  408. ORENSTEIN LAV
    Elevated body mass index, a risk factor or consequence of hidradenitis suppurativa?
    Br J Dermatol. 2021;185:6-7.
    >> Share

  409. DUARTE B, Paiva Lopes MJ
    Response to: 'Successful treatment of refractory extensive pityriasis rubra pilaris with risankizumab'.
    Br J Dermatol. 2021;185:235-236.
    >> Share

  410. THOMPSON AM, Fernandez JM, Rick J, Hendricks AJ, et al
    Identifying triggers for hidradenitis suppurativa flare: a patient survey.
    Br J Dermatol. 2021;185:225-226.
    >> Share

  411. COYER F
    Silicone adhesive multilayered foam dressings for pressure ulcer prevention.
    Br J Dermatol. 2021;185:4-5.
    >> Share

  412. SORIANO LF, Chowdhury MMU, Cooper SM, Cousen P, et al
    Current prevalence and relevance of positive patch test reactions to cosmetic and noncosmetic isothiazolinones in the UK.
    Br J Dermatol. 2021;185:223-225.
    >> Share

  413. YOO DS, Lee JH, Kim SC, Kim JH, et al
    Mortality and clinical response of patients with bullous pemphigoid treated with rituximab.
    Br J Dermatol. 2021;185:210-212.
    >> Share

  414. LIU KX, Huang V, Chen CA, Elco CP, et al
    Longitudinal multicentre retrospective cohort study of treatment outcomes in extramammary Paget disease.
    Br J Dermatol. 2021;185:219-221.
    >> Share

  415. PRENS LM, Bouwman K, Aarts P, Arends S, et al
    Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study.
    Br J Dermatol. 2021;185:177-184.
    >> Share

  416. BETTOLI V, Toni G, Odorici G, Forconi R, et al
    Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa in patients of paediatric age: a pilot prospective study.
    Br J Dermatol. 2021;185:216-217.
    >> Share

  417. QUINN G, MacEochagain C, Mac Mahon J, Killion L, et al
    Actinic keratoses: pain severity after cryotherapy and patient tolerability of treatment.
    Br J Dermatol. 2021;185:234-235.
    >> Share

  418. WOLK K, Brembach TC, Simaite D, Bartnik E, et al
    Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa.
    Br J Dermatol. 2021;185:164-176.
    >> Share

  419. THOMAS KS, Apfelbacher CA, Chalmers JR, Simpson E, et al
    Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
    Br J Dermatol. 2021;185:139-146.
    >> Share

  420. HUGHES AJ, Tawfik SS, Baruah KP, O'Toole EA, et al
    Tape strips in dermatology research.
    Br J Dermatol. 2021;185:26-35.
    >> Share

  421. WRIGHT S, Strunk A, Garg A
    Trends in body mass index before and after diagnosis of hidradenitis suppurativa.
    Br J Dermatol. 2021;185:74-79.
    >> Share

  422. BEECKMAN D, Fourie A, Raepsaet C, Van Damme N, et al
    Silicone adhesive multilayer foam dressings as adjuvant prophylactic therapy to prevent hospital-acquired pressure ulcers: a pragmatic noncommercial multicentre randomized open-label parallel-group medical device trial.
    Br J Dermatol. 2021;185:52-61.
    >> Share

  423. VAN ZUUREN EJ, Arents BWM, Miklas M, Schoones JW, et al
    Identifying and appraising patient-reported outcome measures on treatment satisfaction in acne: a systematic review.
    Br J Dermatol. 2021;185:36-51.
    >> Share

    June 2021
  424. KIM M, Park HE, Han K, Lee J, et al
    Risk of Psoriasis among Survivors of Adult-onset Cancer: A Nationwide Population-based Cohort Study.
    Br J Dermatol. 2021 Jun 30. doi: 10.1111/bjd.20610.
    >> Share

  425. ALTAYEB A, Dawood S, Atwan A, Mills C, et al
    Teledermoscopy: A Helpful Detection Tool for Amelanotic and Hypomelanotic Melanoma.
    Br J Dermatol. 2021 Jun 29. doi: 10.1111/bjd.20609.
    >> Share

  426. HARGADON KM
    The Role of Interferons in Melanoma Resistance to Immune Checkpoint Blockade: Mechanisms of Escape and Therapeutic Implications.
    Br J Dermatol. 2021 Jun 29. doi: 10.1111/bjd.20608.
    >> Share

  427. EGEBERG A, Meteran H, Gyldenlove M, Zachariae C, et al
    Complete clearance of severe plaque psoriasis with 24 weeks of oral roflumilast therapy.
    Br J Dermatol. 2021 Jun 29. doi: 10.1111/bjd.20602.
    >> Share

  428. CARMIGNAC V, Salomon G, Severino-Freire M, Duffourd Y, et al
    Mosaic NEK9 mutation, fibrous dysplasia and premature puberty in nevus comedonicus syndrome.
    Br J Dermatol. 2021 Jun 29. doi: 10.1111/bjd.20603.
    >> Share

  429. O'KANE D, McCourt C, Meggitt S, D'Cruz DP, et al
    British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus (CLE) 2021.
    Br J Dermatol. 2021 Jun 25. doi: 10.1111/bjd.20597.
    >> Share

  430. PAPP KA, Lebwohl MG, Puig L, Ohtsuki M, et al
    Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.
    Br J Dermatol. 2021 Jun 22. doi: 10.1111/bjd.20595.
    >> Share

  431. PATHANIA YS
    Response to 'COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations'.
    Br J Dermatol. 2021 Jun 22. doi: 10.1111/bjd.20590.
    >> Share

  432. BUI H, Skiba PN, Breskin A, Sayed C, et al
    Hidradenitis Suppurativa Among Patients with Human Immunodeficiency Virus: Investigating Patient and Disease Characteristics, and Misdiagnosis.
    Br J Dermatol. 2021 Jun 22. doi: 10.1111/bjd.20591.
    >> Share

  433. SUGAYA M
    Search for the best biologic for psoriasis.
    Br J Dermatol. 2021 Jun 17. doi: 10.1111/bjd.20514.
    >> Share

  434. BRODERICK C, Christian N, Apfelbacher C, Bosma AL, et al
    The BIOMarkers in Atopic Dermatitis and Psoriasis (BIOMAP) Glossary: developing a lingua franca to facilitate data harmonisation and cross-cohort analyses.
    Br J Dermatol. 2021 Jun 16. doi: 10.1111/bjd.20587.
    >> Share

  435. BEYLOT-BARRY M, Seneschal J, Tran D, Bachelez H, et al
    Characteristics of patients with PASI <10 psoriasis treated with biological agents: Results from the French PsoBioTeq cohort.
    Br J Dermatol. 2021 Jun 15. doi: 10.1111/bjd.20585.
    >> Share

  436. KIRBY L, Gran S, Orekoya F, Owen C, et al
    Is urinary incontinence associated with vulval lichen sclerosus in females? A cross-sectional study.
    Br J Dermatol. 2021 Jun 15. doi: 10.1111/bjd.20583.
    >> Share

  437. SKAYEM C, Beylot-Barry M, de Masson A, Dereure O, et al
    Lymph node and visceral progression without erythroderma or blood worsening in erythrodermic cutaneous T-cell lymphoma: nine cases.
    Br J Dermatol. 2021 Jun 15. doi: 10.1111/bjd.20580.
    >> Share

  438. ADAN F, Nelemans PJ, Kelleners-Smeets NWJ, Kessels JPHM, et al
    The additional diagnostic value of optical coherence tomography in clinically diagnosed basal cell carcinomas undergoing direct surgical excision.
    Br J Dermatol. 2021 Jun 14. doi: 10.1111/bjd.20579.
    >> Share

  439. ISKANDAR IYK, Lunt M, Thorneloe RJ, Cordingley L, et al
    Alcohol abuse associated with poor response to systemic therapies for psoriasis: findings from a prospective multicentre cohort study.
    Br J Dermatol. 2021 Jun 14. doi: 10.1111/bjd.20577.
    >> Share

  440. SILVERBERG JI
    Association of atopic dermatitis and autoimmune comorbidities: is it real?
    Br J Dermatol. 2021 Jun 14. doi: 10.1111/bjd.20497.
    >> Share

  441. WIGGINS J, Polsky D
    Melanoma origins: data from early-stage tumours supports de novo and naevus-associated melanomas as distinct subtypes.
    Br J Dermatol. 2021 Jun 11. doi: 10.1111/bjd.20396.
    >> Share

  442. EVERS AWM, van Beugen S
    How stress affects the skin: from designs to mechanisms.
    Br J Dermatol. 2021 Jun 11. doi: 10.1111/bjd.20397.
    >> Share

  443. JOHANSSON EK
    Psychiatric conditions in children with atopic dermatitis.
    Br J Dermatol. 2021 Jun 11. doi: 10.1111/bjd.20394.
    >> Share

  444. LINDER M
    Using epidemiological methods to quantify the risk of serious infections in children with atopic dermatitis.
    Br J Dermatol. 2021 Jun 11. doi: 10.1111/bjd.20395.
    >> Share

  445. AHMADY S, Oyen EMM, Jansen MHE, Nelemans PJ, et al
    Patient-reported skin reactions of 5% 5-fluorouracil in treatment of actinic keratosis.
    Br J Dermatol. 2021 Jun 10. doi: 10.1111/bjd.20570.
    >> Share

  446. GUILLAUME T, Puzenat E, Popescu D, Aubin F, et al
    Cemiplimab-rwlc in Advanced Cutaneous Squamous Cell Carcinoma: a real-life experience in a French Dermatology Department.
    Br J Dermatol. 2021 Jun 9. doi: 10.1111/bjd.20569.
    >> Share

  447. REICH K, Gordon KB, Strober BE, Armstrong AW, et al
    Five-year maintenance of clinical response and improvements in health-related quality of life in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2.
    Br J Dermatol. 2021 Jun 9. doi: 10.1111/bjd.20568.
    >> Share

  448. JOSHI TP, Ren V
    Response to "Evaluating World Health Organization Essential Medicines List for Skin Disease".
    Br J Dermatol. 2021 Jun 9. doi: 10.1111/bjd.20565.
    >> Share

  449. GUHAN S, Klebanov N, Tsao H
    Melanoma genomics: a state-of-the-art review of practical clinical applications.
    Br J Dermatol. 2021 Jun 6. doi: 10.1111/bjd.20421.
    >> Share

  450. BRUNNER PM, Conrad C, Vender R, Grond S, et al
    Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab.
    Br J Dermatol. 2021 Jun 2. doi: 10.1111/bjd.20527.
    >> Share

  451. WELSH E, Cardenas-de la Garza JA, Cuellar-Barboza A, Franco-Marquez R, et al
    SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.
    Br J Dermatol. 2021;184:1194-1195.
    >> Share

  452. BERNIGAUD C, Guillemot D, Ahmed-Belkacem A, Grimaldi-Bensouda L, et al
    Oral ivermectin for a scabies outbreak in a long-term care facility: potential value in preventing COVID-19 and associated mortality.
    Br J Dermatol. 2021;184:1207-1209.
    >> Share


  453. Measuring the success of treatments for squamous cell cancer of the skin.
    Br J Dermatol. 2021;184:e196-e223.
    >> Share

  454. HASHIMOTO T
    Pathogenic role of ST18 in pemphigus vulgaris.
    Br J Dermatol. 2021;184:1001-1002.
    >> Share

  455. GUCKIAN J, Rajan N, Kibbi N
    Incompletely excised keratinocyte carcinomas: more common than once thought?
    Br J Dermatol. 2021;184:991.
    >> Share

  456. COTTER C, Kretz M, Rajan N
    Regulatory noncoding RNAs help protect keratinocytes from ultraviolet-mediated damage in vitiligo.
    Br J Dermatol. 2021;184:999-1000.
    >> Share

  457. BLOME C, Klein TM
    Classifying the severity of bullous pemphigoid disease.
    Br J Dermatol. 2021;184:997-998.
    >> Share

  458. ZOUBOULIS CC
    Pain Index: a new prospective hidradenitis suppurativa patient-reported outcome measure instrument.
    Br J Dermatol. 2021;184:1203-1204.
    >> Share

  459. BUONOMO M, Mansh MD, Thorpe D, Goldfarb N, et al
    Development or exacerbation of hidradenitis suppurativa in two transgender men after initiation of testosterone therapy.
    Br J Dermatol. 2021;184:1192-1194.
    >> Share

  460. GUPTA R, Simonette RA, Doan HQ, Rady PL, et al
    Targeting the expression of T antigens with selinexor (KPT-330) shows promise for Merkel cell polyomavirus-positive Merkel cell carcinoma treatment.
    Br J Dermatol. 2021;184:1185-1187.
    >> Share

  461. SCHMUTH M, Reichelt J, Gruber R
    Advancing novel therapies for ichthyoses.
    Br J Dermatol. 2021;184:998-999.
    >> Share

  462. GAO JM, Garioch JJ, Fadhil M, Tan E, et al
    Planning slow Mohs excision margins for lentigo maligna: a retrospective nonrandomized cohort study comparing reflectance confocal microscopy margin mapping vs. visual inspection with dermoscopy.
    Br J Dermatol. 2021;184:1182-1183.
    >> Share

  463. SMITH J, Ezekwe N, Pourang A, Hamzavi I, et al
    Multifocal myositis and elevated creatine phosphokinase associated with the use of ustekinumab for hidradenitis suppurativa.
    Br J Dermatol. 2021;184:1181-1182.
    >> Share

  464. GRAIER T, Salmhofer W, Jonak C, Weger W, et al
    Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.
    Br J Dermatol. 2021;184:1094-1105.
    >> Share

  465. FELDMAN SR, Huang WW
    Evidence is lacking for or against palmoplantar pustulosis treatments: what does this mean for the clinician.
    Br J Dermatol. 2021;184:990.
    >> Share

  466. CHACKO AM, Lagace F, Jafarian F
    Ultraviolet index and sun safety: are we all on the same page?
    Br J Dermatol. 2021;184:1175-1176.
    >> Share

  467. ASSAF S, Malki L, Mayer T, Mohamad J, et al
    ST18 affects cell-cell adhesion in pemphigus vulgaris in a tumour necrosis factor-alpha-dependent fashion.
    Br J Dermatol. 2021;184:1153-1160.
    >> Share

  468. MASMOUDI W, Vaillant M, Vassileva S, Patsatsi A, et al
    International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid.
    Br J Dermatol. 2021;184:1106-1112.
    >> Share

  469. LI D, Ryu E, Saeidian AH, Youssefian L, et al
    GGCX mutations in a patient with overlapping pseudoxanthoma elasticum/cutis laxa-like phenotype.
    Br J Dermatol. 2021;184:1170-1174.
    >> Share

  470. WAN B, Ganier C, Du-Harpur X, Harun N, et al
    Applications and future directions for optical coherence tomography in dermatology.
    Br J Dermatol. 2021;184:1014-1022.
    >> Share

  471. OBEID G, Do G, Kirby L, Hughes C, et al
    Interventions for chronic palmoplantar pustulosis: abridged Cochrane systematic review and GRADE assessments.
    Br J Dermatol. 2021;184:1023-1032.
    >> Share

  472. NARLA S, Azzam M, Townsend S, Vellaichamy G, et al
    Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils.
    Br J Dermatol. 2021;184:1004-1013.
    >> Share

  473. EBENS CL, McGrath JA, Riedl JA, Keith AR, et al
    Immune tolerance of allogeneic haematopoietic cell transplantation supports donor epidermal grafting of recessive dystrophic epidermolysis bullosa chronic wounds.
    Br J Dermatol. 2021;184:1161-1169.
    >> Share

    May 2021
  474. YEH I, Bastian BC
    Melanoma pathology: new approaches and classification.
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20427.
    >> Share

  475. VENABLES ZC
    Icelandic study of cutaneous squamous cell carcinoma (cSCC) epidemiology highlights the worldwide burden of disease and challenges of in situ and invasive cSCC registry data.
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20422.
    >> Share

  476. TAIEB A, Katoh N
    Regional differences between Japan and the Netherlands in atopic dermatitis patient-reported outcome measures: which interpretation?
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20424.
    >> Share

  477. MAHAMAT-SALEH Y
    Is consumption of citrus associated with a higher risk of melanoma?
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20408.
    >> Share

  478. VESTERGAARD C
    How clinical phenotypes can translate into taxonomy: can we judge atopic dermatitis by its cover?
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20434.
    >> Share

  479. GALLON R, Kibbi N, Cook S, Santibanez-Koref M, et al
    Sebaceous tumours: A prototypical class of skin tumour for universal germline genetic testing.
    Br J Dermatol. 2021 May 29. doi: 10.1111/bjd.20522.
    >> Share

  480. NASR I, McGrath EJ, Harwood CA, Botting J, et al
    British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021.
    Br J Dermatol. 2021 May 29. doi: 10.1111/bjd.20524.
    >> Share

  481. YU W, Barrett J, Liu P, Parameswaran A, et al
    Novel Evidence of Androgen Receptor Immunoreactivity in Skin Tunnels of Hidradenitis Suppurativa: Assessment of Gender and Individual Variability.
    Br J Dermatol. 2021 May 28. doi: 10.1111/bjd.20520.
    >> Share

  482. LWIN SM, Snowden JA, Griffiths CEM
    The Promise and Challenges of Cell Therapy for Psoriasis.
    Br J Dermatol. 2021 May 26. doi: 10.1111/bjd.20517.
    >> Share

  483. RAZMI T M, Afra TP, Mohammed TP, Ashik PTM, et al
    COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations.
    Br J Dermatol. 2021 May 25. doi: 10.1111/bjd.20425.
    >> Share

  484. JONAK C, Alkon N, Rindler K, Rojahn TB, et al
    Single-cell RNAseq profiling in a patient with discordant primary cutaneous B and T cell lymphoma reveals micromilieu-driven immune skewing.
    Br J Dermatol. 2021 May 21. doi: 10.1111/bjd.20512.
    >> Share

  485. ROSELEUR J, Gonzalez-Chica DA, Emery J, Stocks NP, et al
    Skin checks and skin cancer diagnosis in Australian general practice before and during the COVID pandemic, 2011-2020.
    Br J Dermatol. 2021 May 19. doi: 10.1111/bjd.20494.
    >> Share

  486. KHURANA A, Mittal A, Jain R, Mishra A, et al
    Rarity of cutaneous findings among asymptomatic to mildly symptomatic COVID-19 patients admitted to a COVID Care facility in Delhi, India: An observational study.
    Br J Dermatol. 2021 May 16. doi: 10.1111/bjd.20488.
    >> Share

  487. QUEIROS C, Silva L, Miroux Catarino A, Labareda J, et al
    Topical imiquimod as neoadjuvant therapy before Mohs micrographic surgery for basal cell carcinoma in the head and neck region: findings from a large retrospective study.
    Br J Dermatol. 2021 May 16. doi: 10.1111/bjd.20487.
    >> Share

  488. THACI D, Eyerich K, Pinter A, Sebastian M, et al
    Direct Comparison of Risankizumab and Fumaric Acid Esters in Systemic-Therapy-Naive Patients With Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial.
    Br J Dermatol. 2021 May 15. doi: 10.1111/bjd.20481.
    >> Share

  489. DALAL G, Wright SJ, Vass CM, Davison NJ, et al
    Patient preferences for stratified medicine in psoriasis: a discrete choice experiment.
    Br J Dermatol. 2021 May 15. doi: 10.1111/bjd.20482.
    >> Share

  490. GRETHER-BECK S, Felsner I, Brenden H, Marini A, et al
    Air pollution-induced tanning of human skin.
    Br J Dermatol. 2021 May 15. doi: 10.1111/bjd.20483.
    >> Share

  491. CLAESON M, Baade P, Marchetti M, Brown S, et al
    Comparative performance of predictors of death from thin (
    Br J Dermatol. 2021 May 12. doi: 10.1111/bjd.20480.
    >> Share

  492. VAZQUEZ T, Feng R, Williams KJ, Werth VP, et al
    Immunological and clinical heterogeneity in cutaneous lupus erythematosus.

    Br J Dermatol. 2021 May 9. doi: 10.1111/bjd.20085.
    >> Share

  493. SANGERS TE, Wakkee M, Kramer-Noels EC, Nijsten T, et al
    Views on Mobile Health Apps for Skin Cancer Screening in the General Population: An In-Depth Qualitative Exploration of Perceived Barriers and Facilitators.
    Br J Dermatol. 2021 May 7. doi: 10.1111/bjd.20441.
    >> Share

  494. GAUNT N, Green RL, Motta LF, Jamieson LA, et al
    Skin cancers in lockdown: no impact on pathological tumour staging.
    Br J Dermatol. 2021 May 6. doi: 10.1111/bjd.20438.
    >> Share

  495. FLEDDERUS AC, Pasmans SGMA, Wolkerstorfer A, Oei W, et al
    Domains and outcomes of the core outcome set of congenital melanocytic naevi for clinical practice and research, part 2 (the OCOMEN project).
    Br J Dermatol. 2021 May 6. doi: 10.1111/bjd.20437.
    >> Share

  496. CHEN Y, Andre M, Adhikari K, Blin M, et al
    A GWAS identifies novel gene associations with facial skin wrinkling and mole count in Latin-Americans.
    Br J Dermatol. 2021 May 6. doi: 10.1111/bjd.20436.
    >> Share

  497. NGUYEN C, Yale K, Casale F, Ghigi A, et al
    SARS-CoV-2 infection in patients with atopic dermatitis: a cross-sectional study.
    Br J Dermatol. 2021 May 6. doi: 10.1111/bjd.20435.
    >> Share

  498. BECHER G, Burden AD
    Psoriasis, COVID-19 and shielding.
    Br J Dermatol. 2021 May 5. doi: 10.1111/bjd.20055.
    >> Share

  499. SCHNUCH A
    Hand eczema in young people: atopic dermatitis and beyond.
    Br J Dermatol. 2021 May 4. doi: 10.1111/bjd.20142.
    >> Share

  500. ZIMMERMANN C, Boisson M, Ram-Wolff C, Sadoux A, et al
    Diagnostic performance of high throughput sequencing of the T-cell receptor beta gene for the diagnosis of cutaneous T-cell lymphoma.
    Br J Dermatol. 2021 May 3. doi: 10.1111/bjd.20432.
    >> Share

  501. VENABLES ZC, Ahmed S, Bleiker T, Broggio J, et al
    The impact of the COVID-19 pandemic on skin cancer incidence and treatment in England, 2020.
    Br J Dermatol. 2021 May 3. doi: 10.1111/bjd.20409.
    >> Share

  502. WOLKERSTORFER A
    Evidence for efficacy of home-based narrowband ultraviolet B therapy.
    Br J Dermatol. 2021;184:790.
    >> Share

  503. EMTESTAM L, Lapins J, Sartorius K
    A growing family of outcome measurement proposals for hidradenitis suppurativa.
    Br J Dermatol. 2021;184:796-798.
    >> Share

  504. HERISSE AL, Charlesworth A, Bellon N, Leclerc-Mercier S, et al
    Genotypic and phenotypic analysis of 34 cases of inherited junctional epidermolysis bullosa caused by COL17A1 mutations.
    Br J Dermatol. 2021;184:960-962.
    >> Share

  505. JERJEN R, Koh WL, Sinclair R, Bhoyrul B, et al
    Low-dose oral minoxidil improves global hair density and length in children with loose anagen hair syndrome.
    Br J Dermatol. 2021;184:977-978.
    >> Share

  506. ZOUBOULIS CC, Altenburg A
    Interleukin-18 is a sensitive marker of flare initiation in Adamantiades-Behcet disease.
    Br J Dermatol. 2021;184:973-975.
    >> Share

  507. ZIGLER CK, Roberts A
    A child's experience of itch: the first step towards patient-centred measures.
    Br J Dermatol. 2021;184:795-796.
    >> Share

  508. MOLLOY K, Vico C, Ortiz-Romero PL, Scarisbrick JJ, et al
    Real-world experience of using mogamulizumab in relapsed/refractory mycosis fungoides/Sezary syndrome.
    Br J Dermatol. 2021;184:978-981.
    >> Share

  509. KRAIN RL, Bax CE, Chakka S, Ahmed S, et al
    Establishing cut-off values for mild, moderate and severe disease in patients with pemphigus using the Pemphigus Disease Area Index.
    Br J Dermatol. 2021;184:975-977.
    >> Share

  510. MARQUES E, Arenberger P, Smetanova A, Gkalpakiotis S, et al
    Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti-tumour necrosis factor alpha.
    Br J Dermatol. 2021;184:966-967.
    >> Share

  511. ONOUFRIADIS A, Boulouadnine B, Dachy G, Higashino T, et al
    A germline mutation in the platelet-derived growth factor receptor beta gene may be implicated in hereditary progressive mucinous histiocytosis.
    Br J Dermatol. 2021;184:967-970.
    >> Share

  512. BERTOLOTTI A, Sbidian E, Join-Lambert O, Bourgault-Villada I, et al
    Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology.
    Br J Dermatol. 2021;184:963-965.
    >> Share

  513. RICAR J, Cetkovska P
    Successful treatment of refractory extensive pityriasis rubra pilaris with risankizumab.
    Br J Dermatol. 2021;184:e148.
    >> Share

  514. BHANOT A, Peters TJ, Ridd MJ
    Assessing the validity, responsiveness and reliability of the Recap measure of eczema control.
    Br J Dermatol. 2021;184:955-957.
    >> Share

  515. BROWN SJ
    Translational genetics: a challenging but important path.
    Br J Dermatol. 2021;184:800-801.
    >> Share

  516. LEB-REICHL V, Guttmann-Gruber C, Pinon Hofbauer J
    Linked in: the extracellular matrix network in tumour dissemination.
    Br J Dermatol. 2021;184:799.
    >> Share

  517. COTTER C, Ferguson J
    'Ruxolitinib cream for the treatment of vitiligo: a randomised, controlled, phase 2 trial': a critical appraisal.
    Br J Dermatol. 2021;184:826-827.
    >> Share

  518. SIBBALD C
    Long-term safety of dupilumab in children.
    Br J Dermatol. 2021;184:792-793.
    >> Share

  519. ROGERS A, Akram P, Batchelor JM, Crutchley J, et al
    Quality assurance and characterization of narrowband ultraviolet B devices for use at home: lessons from the HI-Light Vitiligo Trial.
    Br J Dermatol. 2021;184:954-955.
    >> Share

  520. ASCOTT A, Mansfield KE, Schonmann Y, Mulick A, et al
    Atopic eczema and obesity: a population-based study.
    Br J Dermatol. 2021;184:871-879.
    >> Share

  521. THOMAS KS, Batchelor JM, Akram P, Chalmers JR, et al
    Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial.
    Br J Dermatol. 2021;184:828-839.
    >> Share

  522. GOLDFARB N, Lowes MA, Butt M, King T, et al
    Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment.
    Br J Dermatol. 2021;184:905-912.
    >> Share

  523. SACH TH, Thomas KS, Batchelor JM, Perways A, et al
    An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial).
    Br J Dermatol. 2021;184:840-848.
    >> Share

  524. PAPANIKOLAOU M, Onoufriadis A, Mellerio JE, Nattkemper LA, et al
    Prevalence, pathophysiology and management of itch in epidermolysis bullosa.
    Br J Dermatol. 2021;184:816-825.
    >> Share

  525. ONOUFRIADIS A, Cabezas A, Ng JCF, Canales J, et al
    Autosomal recessive hypotrichosis with loose anagen hairs associated with TKFC mutations.
    Br J Dermatol. 2021;184:935-943.
    >> Share

  526. LOUSADA MB, Lachnit T, Edelkamp J, Rouille T, et al
    Exploring the human hair follicle microbiome.
    Br J Dermatol. 2021;184:802-815.
    >> Share

    April 2021
  527. IZNARDO H, Vilarrasa E, Lopez-Ferrer A, Puig L, et al
    Real world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis.
    Br J Dermatol. 2021 Apr 29. doi: 10.1111/bjd.20416.
    >> Share

  528. GOTTLIEB AB, Merola JF, Reich K, Behrens F, et al
    Efficacy of secukinumab and adalimumab in psoriatic arthritis patients with concomitant moderate to severe plaque psoriasis: Results from the EXCEED, a randomised, double-blind head-to-head monotherapy study.
    Br J Dermatol. 2021 Apr 29. doi: 10.1111/bjd.20413.
    >> Share

  529. MORENO-ARRONES OM, Ortega-Quijano D, Perez-Brocal V, Fernandez-Nieto D, et al
    Dysbiotic gut microbiota in inflammatory rosacea patients: another clue towards the existence of a brain-gut-skin axis.
    Br J Dermatol. 2021 Apr 29. doi: 10.1111/bjd.20411.
    >> Share

  530. CHAN AA, Noguti J, Yang CT, Feldman SR, et al
    Association between Menopausal Hormone Therapy and Incidence of Psoriasis: A Secondary Analysis from the Women's Health Initiative Randomized Clinical Trials.
    Br J Dermatol. 2021 Apr 29. doi: 10.1111/bjd.20410.
    >> Share

  531. PENSO L, Dray-Spira R, Weill A, Zureik M, et al
    Drop in biological initiation for patients with psoriasis during the COVID-pandemic.
    Br J Dermatol. 2021 Apr 24. doi: 10.1111/bjd.20406.
    >> Share

  532. DOUSSET L, Martins C, Jacquemin C, Amico S, et al
    Complete response in a patient with advanced melanoma following anti-PD-1 therapy is associated with high frequency of melanoma-infiltrating CXCR3(+) resident memory CD8(+) T cells and multiple chemokine pathways.
    Br J Dermatol. 2021 Apr 24. doi: 10.1111/bjd.20405.
    >> Share

  533. SUTARIA N, Parthasarathy V, Roh YS, Choi J, et al
    Itch in Skin of Color: A multicenter cross-sectional study.
    Br J Dermatol. 2021 Apr 24. doi: 10.1111/bjd.20403.
    >> Share

  534. JI-XU A, Lei DK, Nguyen KA, Yang JJ, et al
    The Burden of Immune-Mediated Skin Disease in HIV/AIDS Inpatients.
    Br J Dermatol. 2021 Apr 22. doi: 10.1111/bjd.20401.
    >> Share

  535. DESSINIOTI C, Geller AC, Whiteman DC, Garbe C, et al
    Not all melanomas are created equal: A review and call for more research into nodular melanoma.
    Br J Dermatol. 2021 Apr 16. doi: 10.1111/bjd.20388.
    >> Share

  536. RAIKER R, Pakhchanian H, Hussain A, Deng M, et al
    Outcomes of COVID-19 in Patients with Skin Cancer.
    Br J Dermatol. 2021 Apr 10. doi: 10.1111/bjd.20386.
    >> Share

  537. MAUL JT, Augustin M, Sorbe C, Conrad C, et al
    Association of gender and systemic therapy treatment outcomes in psoriasis: a two-country, multi-centre, prospective, non-interventional registry study.
    Br J Dermatol. 2021 Apr 10. doi: 10.1111/bjd.20387.
    >> Share

  538. LEBWOHL M, Deodhar A, Griffiths CEM, Menter MA, et al
    The risk of malignancy in secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis patients: analysis of up to five-year clinical trial and post-marketing surveillance data.
    Br J Dermatol. 2021 Apr 8. doi: 10.1111/bjd.20136.
    >> Share

  539. CHAN WH, Srivastava R, Damaraju N, Do H, et al
    Automated detection of skin reactions in epicutaneous patch testing using machine learning.
    Br J Dermatol. 2021 Apr 7. doi: 10.1111/bjd.20141.
    >> Share

  540. GEIFMAN N, Azadbakht N, Zeng J, Wilkinson T, et al
    Defining Trajectories of Response in Psoriasis Patients Treated with Biologic Therapies.
    Br J Dermatol. 2021 Apr 7. doi: 10.1111/bjd.20140.
    >> Share

  541. YKEMA BLM, Adan F, Crijns MB, Bleeker FE, et al
    Cutaneous squamous cell carcinoma is associated with Lynch syndrome; widening the spectrum of Lynch syndrome associated tumours.
    Br J Dermatol. 2021 Apr 7. doi: 10.1111/bjd.20139.
    >> Share

  542. VAN DELFT LCJ, Kelleners-Smeets NWJ
    Interventions for basal cell carcinoma: from evidence to personalized treatment.
    Br J Dermatol. 2021 Apr 6. doi: 10.1111/bjd.20059.
    >> Share

  543. KITTLER H
    Total body photography for secondary prevention of melanoma.
    Br J Dermatol. 2021 Apr 6. doi: 10.1111/bjd.20058.
    >> Share

  544. BAURECHT H, Welker C, Baumeister SE, Weidnger S, et al
    Relationship between Atopic Dermatitis, Depression and Anxiety: a two-sample Mendelian randomization study.
    Br J Dermatol. 2021 Apr 4. doi: 10.1111/bjd.20092.
    >> Share

  545. JENDOUBI F, Shourick J, Negretto M, Laurent C, et al
    Cutaneous mastocytosis in adult patients with serum tryptase level under 20 ng/ml: why we should investigate further.
    Br J Dermatol. 2021 Apr 3. doi: 10.1111/bjd.20098.
    >> Share

  546. CARVALHO AF, Machado MO, Mallia E, Liu X, et al
    The Association Between Schizophrenia Spectrum Disorders and Psoriasis: a large-scale population-based case-control study.
    Br J Dermatol. 2021 Apr 2. doi: 10.1111/bjd.20094.
    >> Share

  547. ABO-TABIK M, Parisi R, Willis SC, Griffiths CEM, et al
    Development of clinical diagnostic criteria for chronic plaque psoriasis: an international e-Delphi study.
    Br J Dermatol. 2021 Apr 2. doi: 10.1111/bjd.20096.
    >> Share

  548. SCHMITT T, Egu DT, Walter E, Sigmund AM, et al
    Ca(2+) signalling is critical for autoantibody-induced blistering of human epidermis in pemphigus.
    Br J Dermatol. 2021 Apr 1. doi: 10.1111/bjd.20091.
    >> Share

  549. TOLLENAERE MAX, Hebsgaard J, Ewald DA, Lovato P, et al
    Signaling of multiple IL-17 family cytokines through IL-17RA drive psoriasis-related inflammatory pathways.
    Br J Dermatol. 2021 Apr 1. doi: 10.1111/bjd.20090.
    >> Share


  550. What is the best surgical treatment for dermatofibrosarcoma protuberans?
    Br J Dermatol. 2021;184:e126-e147.
    >> Share

  551. PORCU P, Nikbakht N
    New insights on treatment utilization and outcomes in early-stage mycosis fungoides.
    Br J Dermatol. 2021;184:594-595.
    >> Share

  552. VEERABAGU SA, Lauth MJ, Obayomi A, Correa M, et al
    Hair stylists as screeners for scarring hair loss within the African American community: a cross-sectional study.
    Br J Dermatol. 2021;184:769-770.
    >> Share

  553. MACHADO MO, Lu JD, Brar R, Kirby JS, et al
    Hidradenitis suppurativa odour and drainage scale: a novel method for evaluating odour and drainage in patients with hidradenitis suppurativa.
    Br J Dermatol. 2021;184:772-774.
    >> Share

  554. FROMMHERZ LH, Schempp CM, Has C
    Secukinumab for the treatment of SAM syndrome associated with desmoglein-1 deficiency.
    Br J Dermatol. 2021;184:770-772.
    >> Share

  555. ZHANG J, Qin W, Hua S, Li M, et al
    Cafe au lait macules overlying segmental macular hyperpigmentation in a paediatric patient: an early sign for mosaic neurofibromatosis type 1.
    Br J Dermatol. 2021;184:742-743.
    >> Share

  556. GUTTMANN-GRUBER C, Pinon Hofbauer J
    Transforming growth factor-beta messaging: #ContextMatters.
    Br J Dermatol. 2021;184:592-593.
    >> Share

  557. BRUINSMA RL, Fajgenbaum K, Yang Y, Del Mar Melendez-Gonzalez M, et al
    Assessment of familial risk in patients with hidradenitis suppurativa.
    Br J Dermatol. 2021;184:753-754.
    >> Share

  558. VAN DEN BOS RR
    Dermatofibrosarcoma protuberans: slowly gathering evidence for optimal treatment of a slow-growing tumour.
    Br J Dermatol. 2021;184:595.
    >> Share

  559. AGRAWAL R, Tso S, Eltigani EA, Busam KJ, et al
    PRAME immunohistochemistry as an adjunct in the diagnosis of paucicellular lentigo maligna in a young man.
    Br J Dermatol. 2021;184:e122.
    >> Share

  560. AMRANI A, Das A
    Cydnidae pigmentation: unusual location on the abdomen and back.
    Br J Dermatol. 2021;184:e125.
    >> Share

  561. BONIFAZ A, Fernandez-Samar D, Tirado-Sanchez A, Vazquez-Gonzalez D, et al
    Hidradenitis suppurativa associated with actinomycosis owing to Actinomyces meyeri.
    Br J Dermatol. 2021;184:e123-e124.
    >> Share

  562. OH J, Lee RW, Lee HR, Lee SB, et al
    Classification of facial and truncal segmental vitiligo and its clinical courses including recurrence rate and patterns: a retrospective review of 956 patients.
    Br J Dermatol. 2021;184:750-753.
    >> Share

  563. ZOUBOULIS CC, Readhead B, Dudley JT
    An additional drug repurposing study for hidradenitis suppurativa/acne inversa.
    Br J Dermatol. 2021;184:748-750.
    >> Share

  564. CAPOZZA K
    Never the twain shall meet? Bridging the divide between patient perspectives and health professionals and systems.
    Br J Dermatol. 2021;184:587-588.
    >> Share

  565. ELEFTHERIADOU V
    Outcomes for Pressure Ulcer Trials (OUTPUTs) project: first key step on a long journey.
    Br J Dermatol. 2021;184:587.
    >> Share

  566. WORTSMAN X
    Strong validation of ultrasound as an imaging biomarker in hidradenitis suppurativa.
    Br J Dermatol. 2021;184:591-592.
    >> Share

  567. GRAND D, Frew JW, Navrazhina K, Krueger JG, et al
    Doppler ultrasound-based noninvasive biomarkers in hidradenitis suppurativa: evaluation of analytical and clinical validity.
    Br J Dermatol. 2021;184:688-696.
    >> Share

  568. KIRBY JS, Hereford B, Thorlacius L, Villumsen B, et al
    Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa.
    Br J Dermatol. 2021;184:681-687.
    >> Share

  569. DURACK A, Gran S, Gardiner MD, Jain A, et al
    A 10-year review of surgical management of dermatofibrosarcoma protuberans.
    Br J Dermatol. 2021;184:731-739.
    >> Share

  570. TEASDALE E, Muller I, Sivyer K, Ghio D, et al
    Views and experiences of managing eczema: systematic review and thematic synthesis of qualitative studies.
    Br J Dermatol. 2021;184:627-637.
    >> Share

  571. LECHNER A, Kottner J, Coleman S, Muir D, et al
    Outcomes for Pressure Ulcer Trials (OUTPUTs) project: review and classification of outcomes reported in pressure ulcer prevention research.
    Br J Dermatol. 2021;184:617-626.
    >> Share

    March 2021
  572. MARLEY AR, Li M, Champion VL, Song Y, et al
    The Association between Citrus Consumption and Melanoma Risk in the UK Biobank.
    Br J Dermatol. 2021 Mar 30. doi: 10.1111/bjd.19896.
    >> Share

  573. GHIASVAND R
    Divergent pathways for melanoma: what is the role of genetics?
    Br J Dermatol. 2021 Mar 25. doi: 10.1111/bjd.19887.
    >> Share

  574. RUNDLE CW, Fortugno AP, Maghfour J, Presley CL, et al
    Evaluating World Health Organization Essential Medicines List for Skin Disease.
    Br J Dermatol. 2021 Mar 25. doi: 10.1111/bjd.20081.
    >> Share

  575. VAN VOORHEES AS, Stein Gold L, Lebwohl M, Strober B, et al
    Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: results up to 32 weeks from a randomised, phase 3 study.
    Br J Dermatol. 2021 Mar 24. doi: 10.1111/bjd.20083.
    >> Share

  576. PARK S, Ha KH, Kim TG, Kim HC, et al
    Air pollution and risk of hospital outpatient visits for eczematous skin disorders in metropolitan cities of South Korea.
    Br J Dermatol. 2021 Mar 24. doi: 10.1111/bjd.20079.
    >> Share

  577. O'SHAUGHNESSY RFL
    Ceramide kinase-like protein, 'the kinase that isn't', finds a role in skin cancer stress relief.
    Br J Dermatol. 2021 Mar 23. doi: 10.1111/bjd.19888.
    >> Share

  578. HEPPT MV, Steeb T, Berking C
    One set to collect them all? The development of a core domain set for medium-to-giant congenital melanocytic naevi.
    Br J Dermatol. 2021 Mar 23. doi: 10.1111/bjd.19878.
    >> Share

  579. SHAH P, Svigos K, Yin L, Soter N, et al
    Differences in the Clinical Presentation of Bullous Pemphigoid in Skin of Color and White Patients.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.20068.
    >> Share

  580. SILVERBERG JI, Lai JS, Cella D
    Reliability and meaningful change of the Patient-Reported Outcomes Measurement Information System Itch Questionnaire(R) (PIQ) Item-Banks in adults with atopic dermatitis.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.20066.
    >> Share

  581. TSAI TF
    Secukinumab 2-weekly vs. 4-weekly dosing in plaque-type psoriasis.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.19570.
    >> Share

  582. MOITINHO-SILVA L, Boraczynski N, Emmert H, Baurecht H, et al
    Host traits, lifestyle and environment are associated with the human skin bacteria.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.20072.
    >> Share

  583. THOMPSON LL, Li EB, Krasnow NA, Chang MS, et al
    Effect of Dermatologic Consultation on Survival in Patients with Checkpoint Inhibitor Associated Cutaneous Toxicity.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.20074.
    >> Share

  584. YIU ZZN, Harding G, Griffiths CEM, Warren RB, et al
    Risk of COVID-19 infection in adult patients with atopic eczema and psoriasis: a single centre, cross-sectional study.
    Br J Dermatol. 2021 Mar 17. doi: 10.1111/bjd.20062.
    >> Share

  585. MIRZA FN, Wang A, Ramachandran SM, Damsky W, et al
    Dupilumab induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo IL-17A expression: a case report.
    Br J Dermatol. 2021 Mar 17. doi: 10.1111/bjd.20064.
    >> Share

  586. RAMIEN ML, Bahubeshi A, Lara-Corrales I, Pope E, et al
    Blistering severe cutaneous adverse reactions in children: Proposal for pediatric-focused clinical criteria.
    Br J Dermatol. 2021 Mar 17. doi: 10.1111/bjd.20063.
    >> Share

  587. SCHONMANN Y, Mansfield KE, Mulick A, Roberts A, et al
    Inflammatory Skin Diseases and the Risk of Chronic Kidney Disease - Population-Based Case-control and Cohort analyses.
    Br J Dermatol. 2021 Mar 17. doi: 10.1111/bjd.20067.
    >> Share

  588. OKOJI UK, Taylor SC, Lipoff JB
    Equity in skin typing: why it's time to replace the Fitzpatrick scale.
    Br J Dermatol. 2021 Mar 5. doi: 10.1111/bjd.19932.
    >> Share

  589. NALDI L
    The skin as a target for SARS-CoV-2 infection: exploiting the web for suitable data.
    Br J Dermatol. 2021 Mar 4. doi: 10.1111/bjd.19877.
    >> Share

  590. PEREZ M, Chakraborty A, Lau LS, Mohammed NBB, et al
    Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19891.
    >> Share

  591. BRUGGEN MC, Le ST, Walsh S, Toussi A, et al
    Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19893.
    >> Share

  592. DE WIJS LEM, Fujimoto RFT, Andrinopoulou ER, Nijsten TEC, et al
    Dupilumab treatment in atopic dermatitis patients in the Netherlands versus Japan: a comparative cohort study revealing a discrepancy in patient-reported outcome measures.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19897.
    >> Share

  593. MORRISON PJ, Suhrkamp I, Gerdes S, Mrowietz U, et al
    Oral dimethyl fumarate induces changes within the peripheral neutrophil compartment of psoriasis patients that are linked with skin improvement.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19899.
    >> Share

  594. EL SHAROUNI MA, Varey AHR, Witkamp AJ, Ahmed T, et al
    Predicting sentinel node positivity in melanoma patients: external validation of a risk-prediction calculator (the MIA nomogram) using a large European population-based patient cohort.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19895.
    >> Share

  595. VERMEER M
    Epidemiology of cutaneous lymphoma.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19829.
    >> Share

  596. MULICK AR, Mansfield KE, Silverwood RJ, Buddu-Aggrey A, et al
    Four childhood atopic dermatitis subtypes identified from trajectory and severity of disease and internally validated in a large UK birth cohort.
    Br J Dermatol. 2021 Mar 2. doi: 10.1111/bjd.19885.
    >> Share

  597. LEITER U
    What is new in the 2020 British guidelines for cutaneous squamous cell carcinoma?
    Br J Dermatol. 2021;184:384-385.
    >> Share

  598. HUGO J, Arenbergerova M, Arenberger P, Gkalpakiotis S, et al
    Coexistence of palmoplantar pustulosis and ichthyosis vulgaris treated by risankizumab.
    Br J Dermatol. 2021 Mar 1. doi: 10.1111/bjd.19835.
    >> Share

  599. O'NEILL H, Narang I, Buckley DA, Phillips TA, et al
    Occupational dermatoses during the COVID-19 pandemic: a multicentre audit in the UK and Ireland.
    Br J Dermatol. 2021;184:575-577.
    >> Share

  600. BOUAZZI D, McPhie ML, Kjaersgaard Andersen R, Alavi A, et al
    Hidradenitis suppurativa and perceived stigmatization in a diverse Canadian clinic population: a pilot study.
    Br J Dermatol. 2021;184:570-571.
    >> Share

  601. BAX CE, Ravishankar A, Yan D, Concha J, et al
    Identifying the required degree of disease clearance to improve quality of life in pemphigus vulgaris.
    Br J Dermatol. 2021;184:573-575.
    >> Share

  602. MA Y, Zhao C, Li R, Wang X, et al
    Actinomycetoma caused by Nocardia asiatica associated with traditional Chinese medicine foot bath.
    Br J Dermatol. 2021;184:e55.
    >> Share

  603. HADDAD N, Delyon J, Trabelsi Messai S, Herms F, et al
    Clinical response to immune checkpoint inhibition in patients with advanced skin cancers receiving concurrent ruxolitinib therapy for haematological malignancy.
    Br J Dermatol. 2021;184:564-566.
    >> Share

  604. DE VERE HUNT I, McNiven A, McPherson T
    A qualitative exploration of the experiences of adolescents with alopecia areata and their messages for healthcare professionals.
    Br J Dermatol. 2021;184:557-559.
    >> Share

  605. LU JD, Milakovic M, Piguet V, Alavi A, et al
    Antidrug antibodies to tumour necrosis factor inhibitors in hidradenitis suppurativa: a systematic review.
    Br J Dermatol. 2021;184:555-557.
    >> Share

  606. YAO Y, Jorgensen AR, Ring HC, Thomsen SF, et al
    Effectiveness of clindamycin and rifampicin combination therapy in hidradenitis suppurativa: a 6-month prospective study.
    Br J Dermatol. 2021;184:552-553.
    >> Share

  607. MORENO ARTERO E, Schinkel N, Chaumon S, Corset I, et al
    Efficacy of topical ropivacaine in children and young adults with hereditary epidermolysis bullosa.
    Br J Dermatol. 2021;184:550-552.
    >> Share

  608. JIYAD Z, Marquart L, Green AC
    A call to standardize the BCC:SCC ratio.
    Br J Dermatol. 2021;184:545.
    >> Share

  609. PARARAJASINGAM A, Atwan A, Srivastava P, Chowdhury MMU, et al
    Shades of grey: an outbreak of tattoo-associated Mycobacterium chelonae.
    Br J Dermatol. 2021;184:e54.
    >> Share

  610. HODAK E, Sherman S, Papadavid E, Bagot M, et al
    Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.
    Br J Dermatol. 2021;184:524-531.
    >> Share

  611. GABES M, Jourdan C, Schramm K, Masur C, et al
    Hyperhidrosis Quality of Life Index (HidroQoL(c)): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial.
    Br J Dermatol. 2021;184:473-481.
    >> Share

  612. BODEMER C, Steijlen P, Mazereeuw-Hautier J, O'Toole EA, et al
    Treatment of hereditary palmoplantar keratoderma: a review by analysis of the literature.
    Br J Dermatol. 2021;184:393-400.
    >> Share

    February 2021
  613. KOGAME T, Kambe N, Takimoto-Ito R, Nomura T, et al
    Skin-associated lymphoid tissue could be a sign of systemic disease: reply from authors.
    Br J Dermatol. 2021 Feb 22. doi: 10.1111/bjd.19884.
    >> Share

  614. WANG C
    Skin-associated lymphoid tissue could be a sign of systemic disease.
    Br J Dermatol. 2021 Feb 21. doi: 10.1111/bjd.19881.
    >> Share

  615. SCHNEIDER R, Reinau D, Stoffel S, Jick SS, et al
    Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group.
    Br J Dermatol. 2021 Feb 20. doi: 10.1111/bjd.19880.
    >> Share

  616. ADALSTEINSSON JA, Olafsdottir E, Ratner D, Waldman R, et al
    Invasive and In-Situ Squamous Cell Carcinoma of the Skin: A Nationwide Study in Iceland.
    Br J Dermatol. 2021 Feb 20. doi: 10.1111/bjd.19879.
    >> Share

  617. SOTIRIOU E, Bakirtzi K, Papadimitriou I, Paschou E, et al
    Intention of COVID-19 vaccination among psoriatic patients compared to immunosuppressed patients with other skin diseases and factors influencing their decision.
    Br J Dermatol. 2021 Feb 20. doi: 10.1111/bjd.19882.
    >> Share

  618. PILKINGTON SM
    The importance of keratinocyte-dendritic cell interactions in understanding fragrance allergy.
    Br J Dermatol. 2021 Feb 18. doi: 10.1111/bjd.19828.
    >> Share

  619. ABUABARA K, Nicholls SG, Langan SM, Guttman-Yassky E, et al
    Priority research questions in atopic dermatitis: An International Eczema Council eDelphi consensus.
    Br J Dermatol. 2021 Feb 11. doi: 10.1111/bjd.19874.
    >> Share

  620. HODGES WT, Bhat T, Raval NS, Herbosa C, et al
    Biologics utilization for psoriasis is lower in Black compared to Caucasian patients.
    Br J Dermatol. 2021 Feb 10. doi: 10.1111/bjd.19876.
    >> Share

  621. OMODAKA T, Minagawa A, Okuyama R
    Ultraviolet-related skin cancers distribute differently on the face surface.
    Br J Dermatol. 2021 Feb 10. doi: 10.1111/bjd.19875.
    >> Share

  622. VERMEER HAB, Rashid H, Esajas MD, Oldhoff JM, et al
    The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina.
    Br J Dermatol. 2021 Feb 6. doi: 10.1111/bjd.19870.
    >> Share

  623. TAYLOR MT, Noe MH, Horton DB, Barbieri JS, et al
    Trends in opioid prescribing at outpatient visits for psoriasis and psoriatic arthritis.
    Br J Dermatol. 2021 Feb 5. doi: 10.1111/bjd.19865.
    >> Share

  624. WOLNER ZJ, Flowers NI, Yushak ML, Chen SC, et al
    Exploring the melanoma survivorship experience: a qualitative study.
    Br J Dermatol. 2021 Feb 5. doi: 10.1111/bjd.19868.
    >> Share

  625. THACI D, Piaserico S, Warren RB, Gupta AK, et al
    Five-year efficacy and safety of tildrakizumab in patients with moderate to severe psoriasis who respond at week 28: pooled analyses of two randomised phase 3 clinical trials (reSURFACE 1 and reSURFACE 2).
    Br J Dermatol. 2021 Feb 5. doi: 10.1111/bjd.19866.
    >> Share

  626. NAPOLITANO M, Caiazzo G, Fabbrocini G, Balato A, et al
    Increased expression of interleukin-23A in lesional skin of patients with atopic dermatitis with psoriasiform reaction during dupilumab treatment.
    Br J Dermatol. 2021;184:341-343.
    >> Share

  627. WINGE MCG, Iberri DJ, Novoa RA, Kwong BY, et al
    Telescope punch biopsy of normal-appearing skin to diagnose intravascular lymphoma.
    Br J Dermatol. 2021 Feb 1. doi: 10.1111/bjd.19711.
    >> Share

  628. LUCAS JA
    Using electronic health records to examine links between atopic dermatitis and obesity.
    Br J Dermatol. 2021 Feb 1. doi: 10.1111/bjd.19758.
    >> Share

  629. FLOHR C, Hay R
    Putting the burden of skin diseases on the global map.
    Br J Dermatol. 2021;184:189-190.
    >> Share


  630. Somatostatin receptors: an alternative treatment target for advanced Merkel cell carcinoma.
    Br J Dermatol. 2021;184:e32-e52.
    >> Share

  631. CUST AE
    A different finding on whether naevus numbers change during adulthood.
    Br J Dermatol. 2021;184:193.
    >> Share

  632. FREW JW, Navrazhina K, Sullivan-Whalen M, Gilleaudeau P, et al
    Weekly administration of brodalumab in hidradenitis suppurativa: an open-label cohort study.
    Br J Dermatol. 2021;184:350-352.
    >> Share

  633. GONCALO M, Gimenez-Arnau A, Al-Ahmad M, Ben-Shoshan M, et al
    The global burden of chronic urticaria for the patient and society.
    Br J Dermatol. 2021;184:226-236.
    >> Share

  634. LERTPHANICHKUL C, Smith GP
    Evaluation of malignancy risk in scleroderma by antibody profile.
    Br J Dermatol. 2021;184:369-371.
    >> Share

  635. GARCOVICH S, Tricarico PM, Meddour CN, Giovanardi G, et al
    Comorbid acne inversa and Dowling-Degos disease due to a single NCSTN mutation: is there enough evidence? Reply from the authors.
    Br J Dermatol. 2021;184:375-376.
    >> Share

  636. HERMASCH MA, Schon MP, Frank J
    Comorbid acne inversa and Dowling-Degos disease due to a single NCSTN mutation: is there enough evidence?
    Br J Dermatol. 2021;184:374.
    >> Share

  637. SAMIMI M, Becker J
    There is still a place for tumour-targeted therapies in Merkel cell carcinoma in the era of immune checkpoint inhibitors.
    Br J Dermatol. 2021;184:195-197.
    >> Share

  638. RAMELYTE E, Restivo G, Imhof L, Nageli MC, et al
    How to break resistance to hedgehog inhibitors in advanced basal cell carcinoma?
    Br J Dermatol. 2021;184:359-361.
    >> Share

  639. MIURA H, Takada M, Fujiwara M, Fujiwara S, et al
    Topical imiquimod monotherapy for a recurrent lesion of Merkel cell carcinoma.
    Br J Dermatol. 2021;184:e30.
    >> Share

  640. LAYTON AM, Thiboutot D, Tan J
    Reviewing the global burden of acne: how could we improve care to reduce the burden?
    Br J Dermatol. 2021;184:219-225.
    >> Share

  641. ARDON CB, Wang C, Prens EP, van Straalen KR, et al
    Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches.
    Br J Dermatol. 2021;184:343-345.
    >> Share

  642. SALEVA-STATEVA M, Technau-Hafsi K, Frommherz L, Gruninger G, et al
    Recurrent MVD mutation in European patients with disseminated porokeratosis.
    Br J Dermatol. 2021;184:347-348.
    >> Share

  643. BARBIERI JS
    New oral antifungals for onychomycosis: interesting potential and the need for comparative effectiveness trials.
    Br J Dermatol. 2021;184:191.
    >> Share

  644. ELEWSKI B, Brand S, Degenhardt T, Curelop S, et al
    A phase II, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail.
    Br J Dermatol. 2021;184:270-280.
    >> Share

  645. RIBERO S, Zugna D, Spector T, Bataille V, et al
    Natural history of naevi: a two-wave study.
    Br J Dermatol. 2021;184:289-295.
    >> Share

  646. COX V, Fuller LC, Engelman D, Steer A, et al
    Estimating the global burden of scabies: what else do we need?
    Br J Dermatol. 2021;184:237-242.
    >> Share

  647. LONEY T, Paulo MS, Modenese A, Gobba F, et al
    Global evidence on occupational sun exposure and keratinocyte cancers: a systematic review.
    Br J Dermatol. 2021;184:208-218.
    >> Share

  648. AKAIKE T, Qazi J, Anderson A, Behnia FS, et al
    High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma.
    Br J Dermatol. 2021;184:319-327.
    >> Share

    January 2021
  649. ENDRE KMA, Landro L, LeBlanc M, Gjersvik P, et al
    Diagnosing Atopic Dermatitis in Infancy Using Established Diagnostic Criteria: A Cohort Study.
    Br J Dermatol. 2021 Jan 28. doi: 10.1111/bjd.19831.
    >> Share

  650. SHIIYA C, Aoki S, Nakabayashi K, Hata K, et al
    Linear and disseminated porokeratosis in one family showing identical and independent second hits in MVD among skin lesions, respectively: A proof of concept study.
    Br J Dermatol. 2021 Jan 22. doi: 10.1111/bjd.19824.
    >> Share

  651. TASCILAR K, Bayindir O, Dogru A, Tinazzi I, et al
    Association of Disease Characteristics with the Temporal Sequence of Skin and Musculoskeletal Disease Onset in Psoriatic Arthritis.
    Br J Dermatol. 2021 Jan 22. doi: 10.1111/bjd.19826.
    >> Share

  652. WEHKAMP U, Mitteldorf C, Stendel S, Stranzenbach R, et al
    Most rare subtypes of cutaneous lymphoma display variable CD30 expression. Analysis of the German Cutaneous Lymphoma Network.
    Br J Dermatol. 2021 Jan 22. doi: 10.1111/bjd.19823.
    >> Share

  653. DROITCOURT C, Vittrup I, Dupuy A, Egeberg A, et al
    The risk of systemic infections requiring hospitalisation in children with atopic dermatitis: a Danish retrospective nationwide cohort study.
    Br J Dermatol. 2021 Jan 21. doi: 10.1111/bjd.19825.
    >> Share

  654. DESSINIOTI C, Geller AC, Stergiopoulou A, Dimou N, et al
    A multicenter study of nevus-associated melanoma versus de novo melanoma, tumor thickness and body site differences.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19819.
    >> Share

  655. SILVERBERG JI, Warshaw EM, Maibach HI, DeKoven JG, et al
    Hand Eczema in Children Referred for Patch Testing: North American Contact Dermatitis Group Data, 2000-2016.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19818.
    >> Share

  656. VITTRUP I, Andersen YMF, Droitcourt C, Skov L, et al
    Association between hospital-diagnosed atopic dermatitis and psychiatric disorders and medication use in childhood.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19817.
    >> Share

  657. NAGORE E, Martinez-Garcia MA, Gomez-Olivas JD, Manrique-Silva E, et al
    Relationship between type 2 diabetes mellitus and markers of cutaneous melanoma aggressiveness: An observational multi-centric study in 443 patients with melanoma.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19813.
    >> Share

  658. HICKERSON RP, Conneely MJ, Tsutsumi SKH, Wood K, et al
    Minimal, superficial DNA damage in human skin from filtered far-ultraviolet-C (UV-C).
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19816.
    >> Share

  659. VORNWEG J, Glaser S, Ahmad-Anwar M, Zimmer AD, et al
    Identification of compound heterozygous mutations in AP1B1 leading to the newly-described recessive keratitis-ichthyosis-deafness (KIDAR) syndrome.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19815.
    >> Share

  660. LESTER JC, Clark L Jr, Linos E, Daneshjou R, et al
    Clinical Photography in Skin of Color: Tips and Best Practices.
    Br J Dermatol. 2021 Jan 15. doi: 10.1111/bjd.19811.
    >> Share

  661. THOMSON J, Hogan S, Leonardi-Bee J, Williams HC, et al
    Interventions for basal cell carcinoma: abridged Cochrane systematic review and grade assessments.
    Br J Dermatol. 2021 Jan 15. doi: 10.1111/bjd.19809.
    >> Share

  662. VISCONTI A, Bataille V, Rossi N, Kluk J, et al
    Diagnostic value of cutaneous manifestation of SARS-CoV-2 infection.
    Br J Dermatol. 2021 Jan 14. doi: 10.1111/bjd.19807.
    >> Share

  663. KAMIDO H, Shimomiya D, Kogame T, Takimoto-Ito R, et al
    Inducible skin-associated lymphoid tissue (iSALT) in a patient with Schnitzler syndrome who manifested wheals on recurrent localized erythema.
    Br J Dermatol. 2021 Jan 14. doi: 10.1111/bjd.19808.
    >> Share


  664. Revolutionizing Atopic Dermatitis, 13-14 December 2020.
    Br J Dermatol. 2021 Jan 11. doi: 10.1111/bjd.19722.
    >> Share

  665. ABADIAS-GRANADO I, Navarro-Bielsa A, Morales-Callaghan AM, Roc L, et al
    COVID-19-associated cutaneous manifestations: does HHV-6 play an etiological role?
    Br J Dermatol. 2021 Jan 8. doi: 10.1111/bjd.19806.
    >> Share

  666. GIANOTTI R, Barberis M, Fellegara G, Galvan-Casas C, et al
    COVID-19 related dermatosis in November 2019. Could this case be Italy's patient zero?
    Br J Dermatol. 2021 Jan 7. doi: 10.1111/bjd.19804.
    >> Share

  667. KELLY A, Meurling J, Kirthi Jeyarajah S, Ryan C, et al
    Obstructive Sleep Apnea in Psoriasis and Hidradenitis Suppurativa.
    Br J Dermatol. 2021 Jan 6. doi: 10.1111/bjd.19802.
    >> Share

  668. LAN Y, Zeng W, Dong X, Lu H, et al
    Opsin 5 is a key regulator of ultraviolet radiation induced melanogenesis in human epidermal melanocytes.
    Br J Dermatol. 2021 Jan 5. doi: 10.1111/bjd.19797.
    >> Share

  669. ZHU JL, Tran LT, Smith M, Zheng F, et al
    Modular gene analysis reveals distinct molecular signatures for cutaneous lupus patient subsets.
    Br J Dermatol. 2021 Jan 5. doi: 10.1111/bjd.19800.
    >> Share

  670. LOH AYT, Ho CM, Muthiah S, Venkatesh B, et al
    Huriez syndrome caused by a large deletion that abrogates the skin-specific isoform of SMARCAD1.
    Br J Dermatol. 2021 Jan 5. doi: 10.1111/bjd.19799.
    >> Share

  671. MEYER JM, Lee E, Celli A, Park K, et al
    CERKL is upregulated in cutaneous squamous cell carcinoma and maintains cellular sphingolipids and resistance to oxidative stress.
    Br J Dermatol. 2021 Jan 4. doi: 10.1111/bjd.19753.
    >> Share

  672. GAULT A, Anderson AE, Plummer R, Stewart C, et al
    Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors.
    Br J Dermatol. 2021 Jan 4. doi: 10.1111/bjd.19750.
    >> Share

  673. SOARES CD, Mosqueda-Taylor A, de Carvalho MGF, de Almeida OP, et al
    Oral vesiculobullous lesions as an early sign of COVID-19: immunohistochemical detection of SARS-CoV-2 spike protein.
    Br J Dermatol. 2021;184:e6.
    >> Share

  674. DERRICK KM, Mazori DR, Heilman ER, Glick SA, et al
    Prurigo pigmentosa and new-onset type 1 diabetes in a black female patient testing positive for SARS-CoV-2 IgG.
    Br J Dermatol. 2021;184:e5.
    >> Share

  675. NUNO-GONZALEZ A, Martin-Carrillo P, Magaletsky K, Martin Rios MD, et al
    Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findings.
    Br J Dermatol. 2021;184:184-185.
    >> Share

  676. LIMA XT, Cueva MA, Alora MB
    COVID-19 in patients with hidradenitis suppurativa.
    Br J Dermatol. 2021;184:182-184.
    >> Share

  677. FERGUSON FJ, Street G, Cunningham L, White IR, et al
    Occupational dermatology in the time of the COVID-19 pandemic: a report of experience from London and Manchester, UK.
    Br J Dermatol. 2021;184:180-182.
    >> Share

  678. MAGRO CM, Mulvey JJ, Laurence J, Sanders S, et al
    The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.
    Br J Dermatol. 2021;184:141-150.
    >> Share

  679. CHEN E, Ghannoum M, Elewski BE
    Treatment-resistant tinea corporis, a potential public health issue.
    Br J Dermatol. 2021;184:164-165.
    >> Share


  680. Trim21 promotes inflammation in keratinocytes of psoriatic patients.
    Br J Dermatol. 2021;184:e7-e28.
    >> Share

  681. OHYAMA M
    Caffeine relaxes hair follicles in androgenetic alopecia.
    Br J Dermatol. 2021;184:7-8.
    >> Share

  682. GUPTA V, Taneja N, Sati HC, Sreenivas V, et al
    Evaluation of 'not relevant' responses on the Dermatology Life Quality Index (DLQI) and the DLQI-R scoring modification among Indian patients with vitiligo.
    Br J Dermatol. 2021;184:168-169.
    >> Share

  683. EXPOSITO-SERRANO V, Curto-Barredo L, Aguilera Peiro P, Gomez Armayones S, et al
    Omalizumab for the treatment of chronic inducible urticaria in 80 patients.
    Br J Dermatol. 2021;184:167-168.
    >> Share

  684. NARAYAN VS, Uitentuis SE, Bekkenk MW, Wolkerstorfer A, et al
    What is successful repigmentation in vitiligo from the point of view of patients?
    Br J Dermatol. 2021;184:165-166.
    >> Share

  685. FERNANDEZ JM, Thompson AM, Kirby JS, Hsiao JL, et al
    Characterizing physical symptoms of flare in hidradenitis suppurativa: a patient survey.
    Br J Dermatol. 2021;184:160-162.
    >> Share

  686. BOONCHAI W
    What should be in the facial patch testing series for 2020?
    Br J Dermatol. 2021;184:13.
    >> Share

  687. BAX CE, Werth VP
    The incidence of bullous pemphigoid continues to increase in England.
    Br J Dermatol. 2021;184:5-6.
    >> Share

  688. ZOUBOULIS CC
    First real-world data provide evidence for a 'window of opportunity' in treatment of hidradenitis suppurativa/acne inversa.
    Br J Dermatol. 2021;184:10-11.
    >> Share

  689. PERSSON MSM, Harman KE, Vinogradova Y, Langan SM, et al
    Incidence, prevalence and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study.
    Br J Dermatol. 2021;184:68-77.
    >> Share

  690. MARZANO AV, Genovese G, Casazza G, Moltrasio C, et al
    Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study.
    Br J Dermatol. 2021;184:133-140.
    >> Share

  691. INGRAM JR, Ahluwalia A
    The pharmacology of itch.
    Br J Dermatol. 2021;184:e1-e2.
    >> Share

    December 2020
  692. TOLAND AE
    The influence of sex, age and sunlight exposure on mutational processes in melanoma.
    Br J Dermatol. 2020 Dec 28. doi: 10.1111/bjd.19336.
    >> Share

  693. VAN DER KRAAIJ GE, van Huizen AM, Baerveldt EM, Boshuizen M, et al
    Online decision aid for patients with psoriasis.
    Br J Dermatol. 2020 Dec 28. doi: 10.1111/bjd.19761.
    >> Share

  694. JI-XU A, Dinnes J, Matin RN
    Total Body Photography for the Diagnosis of Cutaneous Melanoma in Adults: A Systematic Review and Meta-Analysis.
    Br J Dermatol. 2020 Dec 28. doi: 10.1111/bjd.19759.
    >> Share

  695. MAHIL SK, Yates M, Langan SM, Yiu ZZN, et al
    Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.
    Br J Dermatol. 2020 Dec 23. doi: 10.1111/bjd.19755.
    >> Share

  696. PUIG L
    Head-to-head comparison of biologics in psoriasis: better acceleration does not necessarily win all races.
    Br J Dermatol. 2020 Dec 21. doi: 10.1111/bjd.19696.
    >> Share

  697. MORRA DE, Drucker AM
    Tralokinumab for atopic dermatitis: a promising new therapy.
    Br J Dermatol. 2020 Dec 21. doi: 10.1111/bjd.19699.
    >> Share

  698. KASSARDJIAN AA, Chat VS, Archuleta L, Hekmatjah J, et al
    Words Matter: A randomized controlled study evaluating the impact of decision-framing on treatment preferences in adults with psoriasis and psoriatic arthritis.
    Br J Dermatol. 2020 Dec 17. doi: 10.1111/bjd.19746.
    >> Share

  699. HAMM H, Wilsmann-Theis D, Tsianakas A, Gambichler T, et al
    Efficacy and safety of fumaric acid esters in young patients aged 10 to 17 years with moderate-to-severe plaque psoriasis - A randomised, double-blinded, placebo-controlled trial.
    Br J Dermatol. 2020 Dec 17. doi: 10.1111/bjd.19747.
    >> Share

  700. GREIG A, Aloni K, Orchard G, Shams M, et al
    Treatment of multiple facial basal cell carcinomas in a child with xeroderma pigmentosum complementation group C with Mohs micrographic surgery.
    Br J Dermatol. 2020 Dec 16. doi: 10.1111/bjd.19323.
    >> Share

  701. TOBIN DJ
    Unpicking the Gordian knot of identifying metastasis development-relevant proteins in cutaneous squamous cell carcinoma.
    Br J Dermatol. 2020 Dec 16. doi: 10.1111/bjd.19697.
    >> Share

  702. RUINI C, Schuh S, Hartmann D, French L, et al
    Noninvasive real-time imaging of mite skin infestations with line-field confocal optical coherence tomography.
    Br J Dermatol. 2020 Dec 14. doi: 10.1111/bjd.19318.
    >> Share

  703. BERGQVIST C, Stern RS, Chosidow O
    Psoriasis: an example of the complexity of decision-making.
    Br J Dermatol. 2020 Dec 10. doi: 10.1111/bjd.19715.
    >> Share

  704. GEHLHAUSEN JR, Ko CJ, Damsky W
    Response to Tembhre et al.: 'Enhanced expression of ACE2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: Implication of inflammatory milieu in skin tropism of SARS-CoV-2'.
    Br J Dermatol. 2020 Dec 10. doi: 10.1111/bjd.19714.
    >> Share

  705. DESCALZO MA, Garcia-Doval I
    Association of skin diseases, biological treatment and COVID-19 during the first wave of the pandemic.
    Br J Dermatol. 2020 Dec 4. doi: 10.1111/bjd.19683.
    >> Share

  706. MEYER JM, Lee E, Celli A, Park K, et al
    CERKL is Upregulated in Cutaneous Squamous Cell Carcinoma and Maintains Cellular Sphingolipids and Resistance to Oxidative Stress.
    Br J Dermatol. 2020 Dec 3. doi: 10.1111/bjd.19707.
    >> Share

  707. VUONG K, Armstrong BK, Espinoza D, Hopper JL, et al
    An independent external validation of melanoma risk prediction models using the Australian Melanoma Family Study.
    Br J Dermatol. 2020 Dec 3. doi: 10.1111/bjd.19706.
    >> Share

  708. LASKAR R, Ferreiro-Iglesias A, Bishop DT, Iles MM, et al
    Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity.
    Br J Dermatol. 2020 Dec 3. doi: 10.1111/bjd.19705.
    >> Share

  709. MCALEER MA, Jakasa I, Stefanovic N, McLean WHI, et al
    Topical Corticosteroids Normalize both Skin and Systemic Inflammatory Markers in Infant Atopic Dermatitis.
    Br J Dermatol. 2020 Dec 2. doi: 10.1111/bjd.19703.
    >> Share

  710. PAN CX, Jee YH, Moore KJ, Kraft P, et al
    Relationship Between Body Mass Index and Atopic Dermatitis: Critical Appraisal of a Mendelian Randomization Approach in Exploring Causality.
    Br J Dermatol. 2020 Dec 1. doi: 10.1111/bjd.19702.
    >> Share

  711. BABAKINEJAD P, Hampton PJ
    New brodalumab psoriasis outcome data suggests that intermittent treatment is as effective as continuous dosing. Is it time to re-evaluate our treatment regimens?
    Br J Dermatol. 2020;183:984-985.
    >> Share


  712. Why don't people with psoriasis take enough exercise?
    Br J Dermatol. 2020;183:e191-e200.
    >> Share

  713. PENDSE RS, Schwartz BL, Jia JL, Bailey EE, et al
    Paucity of COVID-19 dermatology literature from low- and middle-income countries.
    Br J Dermatol. 2020;183:1142-1143.
    >> Share

  714. XU R, Zhou Y, Cai L, Wang L, et al
    Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19.
    Br J Dermatol. 2020;183:1145-1147.
    >> Share

  715. RENCZ F
    A new self-reported measure of disease severity of scalp hair loss in alopecia areata.
    Br J Dermatol. 2020;183:986-987.
    >> Share

    November 2020
  716. BESSIS D
    Impaired type I interferon response in SARS-CoV-2 infection: looking through the cutaneous window.
    Br J Dermatol. 2020 Nov 29. doi: 10.1111/bjd.19596.
    >> Share

  717. OEI W, Fledderus AC, Spuls PI, Eggen CAM, et al
    Development of an international core domain set for medium, large and giant congenital melanocytic nevi as a first step towards a core outcome set for clinical practice and research.
    Br J Dermatol. 2020 Nov 25. doi: 10.1111/bjd.19694.
    >> Share

  718. REYNOLDS KA, Schlessinger DI, Yanes AF, Godinez-Puig V, et al
    Development of a Core Outcome Set for Cutaneous Squamous Cell Carcinoma Trials: Identification of Core Domains and Outcomes.
    Br J Dermatol. 2020 Nov 25. doi: 10.1111/bjd.19693.
    >> Share

  719. REICH K, Sorbe C, Griese L, Reich JLK, et al
    The value of subcutaneous versus oral methotrexate - real-world data from the German psoriasis registry PsoBest.
    Br J Dermatol. 2020 Nov 21. doi: 10.1111/bjd.19690.
    >> Share

  720. PATEL S, Cadwell JB, Lambert WC
    Comparison of adult versus paediatric staphylococcal scalded skin syndrome inpatients: A retrospective database analysis.
    Br J Dermatol. 2020 Nov 20. doi: 10.1111/bjd.19691.
    >> Share

  721. NAKAMURA M, Obayashi M, Yoshimitsu M, Kato H, et al
    Comparative whole-exome sequencing of an ultra-late recurrent malignant melanoma.
    Br J Dermatol. 2020 Nov 18. doi: 10.1111/bjd.19680.
    >> Share

  722. LICHTER J, Silva E Sousa M, Peter N, Sahli F, et al
    Skin sensitisation to fragrance hydroperoxides: interplay between dendritic cells, keratinocytes and free radicals.
    Br J Dermatol. 2020 Nov 18. doi: 10.1111/bjd.19685.
    >> Share

  723. ZIAJ S, Tseliou F, Datta D, Abbott RA, et al
    Skin cancer awareness and prevention behaviour in Wales.
    Br J Dermatol. 2020 Nov 11. doi: 10.1111/bjd.19676.
    >> Share

  724. GROOT J, Blegvad C, Nybo Andersen AM, Zachariae C, et al
    Presence of streptococci and frequent tonsillitis among adolescents with psoriasis.
    Br J Dermatol. 2020 Nov 10. doi: 10.1111/bjd.19672.
    >> Share

  725. MIYANO T, Tanaka RJ
    Identification of keratinocyte subpopulations in transcriptome to evaluate drug effects in atopic dermatitis.
    Br J Dermatol. 2020 Nov 8. doi: 10.1111/bjd.19615.
    >> Share

  726. VAZQUEZ T, Concha JSS, Werth VP
    Patient-oriented outcomes for atopic dermatitis.
    Br J Dermatol. 2020 Nov 8. doi: 10.1111/bjd.19614.
    >> Share

  727. VERMEER MH, Nicolay JP, Scarisbrick JJ, Zinzani PL, et al
    The importance of assessing blood tumour burden in cutaneous T-cell lymphoma.
    Br J Dermatol. 2020 Nov 6. doi: 10.1111/bjd.19669.
    >> Share

  728. TEMBHRE MK, Parihar AS, Sharma VK, Imran S, et al
    Enhanced expression of ACE2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: Implication of inflammatory milieu in skin tropism of SARS-CoV-2.
    Br J Dermatol. 2020 Nov 6. doi: 10.1111/bjd.19670.
    >> Share

  729. VAN WINDEN MEC, Ter Haar ELM, Groenewoud JMM, van de Kerkhof PCM, et al
    Quality of life, treatment goals, preferences and satisfaction in older adults with psoriasis: a patient survey comparing age groups.
    Br J Dermatol. 2020 Nov 5. doi: 10.1111/bjd.19665.
    >> Share

  730. BRAHMBHATT HD, Gupta R, Gupta A, Rastogi S, et al
    Long non-coding RNA MALAT1 suppresses miR-211 to confer protection from UV-mediated DNA damage in vitiligo epidermis by upregulating SIRT1.
    Br J Dermatol. 2020 Nov 5. doi: 10.1111/bjd.19666.
    >> Share

  731. MURRAY G, Roche D, Ridge A, Hackett C, et al
    Response to "Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic".
    Br J Dermatol. 2020 Nov 5. doi: 10.1111/bjd.19667.
    >> Share

  732. KEOHANE SG, Botting J, Budny PG, Dolan OM, et al
    British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020.
    Br J Dermatol. 2020 Nov 4. doi: 10.1111/bjd.19621.
    >> Share

  733. PATALAY R
    Which method is better for the diagnosis of basal cell carcinoma: biopsy vs. reflectance confocal microscopy?
    Br J Dermatol. 2020 Nov 2. doi: 10.1111/bjd.19571.
    >> Share


  734. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS((R)) ) Itch Questionnaire: itch severity assessments in adults with atopic dermatitis.
    Br J Dermatol. 2020;183:e149-e170.
    >> Share

  735. SIMONSEN AB, Ruge IF, Quaade AS, Johansen JD, et al
    High incidence of hand eczema in Danish schoolchildren following intensive hand hygiene during the COVID-19 pandemic: a nationwide questionnaire study.
    Br J Dermatol. 2020;183:975-976.
    >> Share

  736. VAN DELFT LCJ, Essers BAB, Nelemans PJ, Mosterd K, et al
    Development of a patient decision aid for superficial basal-cell carcinoma.
    Br J Dermatol. 2020 Nov 1. doi: 10.1111/bjd.19662.
    >> Share

  737. WANG HL, Sun J, Qian ZM, Gong YQ, et al
    Association between Air Pollution and Atopic Dermatitis in Guangzhou, China: Modification by Age and Season.
    Br J Dermatol. 2020 Nov 1. doi: 10.1111/bjd.19645.
    >> Share

  738. ELEWSKI B
    A call for antifungal stewardship.
    Br J Dermatol. 2020;183:798-799.
    >> Share

  739. MATOS TR
    Is targeting circulating T blood cells a therapeutic option for vitiligo?
    Br J Dermatol. 2020;183:803.
    >> Share

  740. SCHUTTELAAR MLA
    The value of ongoing surveillance on the prevalence of contact sensitization.
    Br J Dermatol. 2020;183:800-801.
    >> Share

  741. ELEFTHERIADOU V
    Reliability and validity of the Vitiligo Signs of Activity Score.
    Br J Dermatol. 2020;183:801-802.
    >> Share

  742. KIRBY B, Fitzgerald O
    A new biomarker for psoriatic arthritis?
    Br J Dermatol. 2020;183:805-806.
    >> Share

  743. BELLON T, Kardaun SH
    CXCL10/IP-10, an early biomarker for late sequelae in DRESS?
    Br J Dermatol. 2020;183:804-805.
    >> Share

    October 2020
  744. NOLAN GS, Kiely AL, Totty JP, Wormald J, et al
    Incomplete surgical excision of keratinocyte skin cancers: a systematic review and meta-analysis.
    Br J Dermatol. 2020 Oct 31. doi: 10.1111/bjd.19660.
    >> Share

  745. DOBOS G, de Masson A, Ram-Wolff C, Beylot-Barry M, et al
    Epidemiological changes in cutaneous lymphomas: an analysis of 8,593 patients from the French Cutaneous Lymphoma Registry.
    Br J Dermatol. 2020 Oct 31. doi: 10.1111/bjd.19644.
    >> Share

  746. SEARS AV, Woolf RT, Gribaleva E, Abdelrahman W, et al
    Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: A single centre, prospective one-year observational cohort study of the first 100 patients treated.
    Br J Dermatol. 2020 Oct 27. doi: 10.1111/bjd.19631.
    >> Share

  747. CHARVET E, Kramkimel N, Chaplain L, Gantzer A, et al
    Second primary cutaneous melanoma in patients with advanced melanoma treated with anti-PD-1 monoclonal antibodies.
    Br J Dermatol. 2020 Oct 24. doi: 10.1111/bjd.19629.
    >> Share

  748. IVERT LU, Wahlgren CF, Lindelof B, Dal H, et al
    Association between atopic dermatitis and autoimmune diseases: a population-based case-control study.
    Br J Dermatol. 2020 Oct 22. doi: 10.1111/bjd.19624.
    >> Share

  749. MARUTHAPPU T, Bewley A
    A changed life: the life experiences of patients with psoriasis receiving biological treatment.
    Br J Dermatol. 2020 Oct 21. doi: 10.1111/bjd.19623.
    >> Share

  750. WOLINER-VAN DER WEG W, Peppelman M, van Erp PEJ, Lubeek SFK, et al
    Lost in translation: True Clinical Impact of RCM Overlooked in "Biopsy outperforms Reflectance Confocal Microscopy in Diagnosing and Subtyping Basal Cell Carcinoma: Results and Experiences from a Randomized Controlled Multicentre Trial": reply from au
    Br J Dermatol. 2020 Oct 15. doi: 10.1111/bjd.19605.
    >> Share

  751. GILL M, Pellacani G, Grant-Kels JM, Ardigo M, et al
    Lost in Translation: True Clinical Impact of RCM Overlooked in "Biopsy outperforms Reflectance Confocal Microscopy in Diagnosing and Subtyping Basal Cell Carcinoma: Results and Experiences from a Randomized Controlled Multicentre Trial".
    Br J Dermatol. 2020 Oct 14. doi: 10.1111/bjd.19602.
    >> Share

  752. SORIANO LF, Bertram CG, Chowdhury MMU, Cousen P, et al
    Prevalence of allergic contact dermatitis to decyl and lauryl glucoside in the UK and Ireland.
    Br J Dermatol. 2020 Oct 14. doi: 10.1111/bjd.19603.
    >> Share

  753. GHIASVAND R, Khosrotehrani K, Hughes MCB, von Schuckmann LA, et al
    Patient age and risk of recurrence of primary melanoma at high risk of spread.
    Br J Dermatol. 2020 Oct 14. doi: 10.1111/bjd.19601.
    >> Share

  754. SCHMITT-EGENOLF M
    Complete skin clearance and beyond.
    Br J Dermatol. 2020 Oct 8. doi: 10.1111/bjd.19544.
    >> Share

  755. LAUGHTER MR, Maymone MBC, Mashayekhi S, Arents BWM, et al
    The global burden of atopic dermatitis: lessons from the GBD Study - 1990 to 2017.
    Br J Dermatol. 2020 Oct 2. doi: 10.1111/bjd.19580.
    >> Share

  756. REICH K
    A new treatment option for paediatric psoriasis.
    Br J Dermatol. 2020;183:606-607.
    >> Share

  757. CASELLI D, Chironna M, Loconsole D, Nigri L, et al
    No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain.
    Br J Dermatol. 2020;183:784-785.
    >> Share

  758. NAIK HB, Alhusayen R, Frew J, Guilbault S, et al
    Global Hidradenitis Suppurativa COVID-19 Registry: a registry to inform data-driven management practices.
    Br J Dermatol. 2020;183:780-781.
    >> Share

  759. SANTONJA C, Heras F, Nunez L, Requena L, et al
    COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient.
    Br J Dermatol. 2020;183:778-780.
    >> Share

  760. COLMENERO I, Santonja C, Alonso-Riano M, Noguera-Morel L, et al
    SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
    Br J Dermatol. 2020;183:729-737.
    >> Share

  761. MOHD MUSTAPA MF, de Berker D, McGregor JM, Exton LS, et al
    Suspension of marketing authorization for ingenol mebutate.
    Br J Dermatol. 2020;183:792.
    >> Share

  762. POPE E
    Epidermolysis bullosa: a 2020 perspective.
    Br J Dermatol. 2020;183:603.
    >> Share

  763. BLOME C
    Percentage of scalp-hair loss as a primary endpoint in alopecia areata trials.
    Br J Dermatol. 2020;183:609.
    >> Share

  764. CLARK KEN, Denton CP
    The patient knows best: a new self-reported outcome measure for systemic sclerosis.
    Br J Dermatol. 2020;183:610.
    >> Share

  765. STEEB T, Heppt MV, Berking C
    Cash is king: the balance of costs and effectiveness of treatments for actinic keratosis.
    Br J Dermatol. 2020;183:612.
    >> Share

  766. HAUGAARD JH, Egeberg A
    Do we need to fear methotrexate?
    Br J Dermatol. 2020;183:608-609.
    >> Share

    September 2020
  767. SILVERBERG JI, Toth D, Bieber T, Alexis AF, et al
    Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.
    Br J Dermatol. 2020 Sep 30. doi: 10.1111/bjd.19573.
    >> Share

  768. WOLLENBERG A, Blauvelt A, Guttman-Yassky E, Worm M, et al
    Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).
    Br J Dermatol. 2020 Sep 30. doi: 10.1111/bjd.19574.
    >> Share

  769. REDDY R, Pannu S, Fiumara K, Kahn J, et al
    Efficacy of in-class IL-23 inhibitor switching: Risankizumab following Guselkumab failure in moderate-to-severe psoriasis treatment.
    Br J Dermatol. 2020 Sep 30. doi: 10.1111/bjd.19575.
    >> Share

  770. NETTIS E, Fabbrocini G, Ortoncelli M, Pellacani G, et al
    Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients.
    Br J Dermatol. 2020 Sep 30. doi: 10.1111/bjd.19577.
    >> Share

  771. CORK MJ, Thaci D, Eichenfield LF, Arkwright PD, et al
    Dupilumab provides favourable long-term safety and efficacy in children aged >/= 6 to < 12 years with uncontrolled, severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study.
    Br J Dermatol. 2020 Sep 24. doi: 10.1111/bjd.19460.
    >> Share

  772. POLAK ME
    Early life regulation of inflammation in atopic dermatitis by microRNA.
    Br J Dermatol. 2020 Sep 20. doi: 10.1111/bjd.19475.
    >> Share

  773. JOHNSON MC, Heron CE, Feldman SR
    Long-term efficacy of certolizumab pegol for psoriasis.
    Br J Dermatol. 2020 Sep 20. doi: 10.1111/bjd.19537.
    >> Share

  774. DELALEU J, Battistella M, Rathana K, Vignon-Pennamen MD, et al
    Identification of Clonal Skin Myeloid Cells by Next Generation Sequencing in Myelodysplasia Cutis.
    Br J Dermatol. 2020 Sep 10. doi: 10.1111/bjd.19547.
    >> Share

  775. NAVARRO-NAVARRO I, Jimenez-Gallo D, Valenzuela-Ubina S, Dominguez-Gomez M, et al
    Infantile bullous pemphigoid following serogroup B meningococcal vaccination.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19480.
    >> Share

  776. KIM Y, Jorgenson E, Asgari MM
    Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis.
    Br J Dermatol. 2020;183:415-416.
    >> Share

  777. HAMPTON PJ
    Expanding treatment options for rosacea.
    Br J Dermatol. 2020;183:412-413.
    >> Share

  778. DRABO EF, Levy JF, Gaskin DJ
    Yes, accurately measuring and valuing health-related productivity loss is important, but can we afford any longer not to prevent and address it?
    Br J Dermatol. 2020;183:420-421.
    >> Share

  779. PATTINSON R, Bundy C
    Self-management: PROMs can prompt support.
    Br J Dermatol. 2020;183:418-419.
    >> Share

    August 2020
  780. SILVERBERG JI, Lei D, Yousaf M, Janmohamed SR, et al
    What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice? A prospective observational study.
    Br J Dermatol. 2020 Aug 5. doi: 10.1111/bjd.19457.
    >> Share

  781. SAMIMI M, Kelleners-Smeets N
    Innovative devices for actinic keratoses: a hot-button issue.
    Br J Dermatol. 2020;183:197-199.
    >> Share

  782. NIXON J
    Silicone dressings for pressure ulcer prevention.
    Br J Dermatol. 2020;183:200-201.
    >> Share

  783. PRIOR J
    Understanding how young people perceive acne and acne treatments.
    Br J Dermatol. 2020;183:208-209.
    >> Share

  784. MEIER K, Ghoreschi K
    Among the brightest antipsoriatic stars.
    Br J Dermatol. 2020;183:201-202.
    >> Share

  785. MAGIN P
    A novel approach to understanding potential risk factors for venous leg ulceration.
    Br J Dermatol. 2020;183:207-208.
    >> Share

  786. ARENTS BWM, Leonardi-Bee J
    Eczema and water hardness: another piece of the puzzle found?
    Br J Dermatol. 2020;183:203-204.
    >> Share

  787. PATEL ZS, Hoffman LK, Sutton L, Cohen SR, et al
    The patient experience of pain in hidradenitis suppurativa.
    Br J Dermatol. 2020;183:401-402.
    >> Share

    July 2020
  788. GLOOR AD, Feldmeyer L, Rammlmair A, Schlapbach C, et al
    A relapsing localized variant of neutrophilic dermatosis triggered by tissue injury.
    Br J Dermatol. 2020 Jul 29. doi: 10.1111/bjd.19418.
    >> Share

  789. SHEEN YS, Chu CY
    Co-occurrence of TERT promotor mutations with BRAF or NRAS alterations correlates with worse prognosis in melanoma.
    Br J Dermatol. 2020 Jul 22. doi: 10.1111/bjd.19416.
    >> Share

  790. DURACK A, Holden ST, Burrows NP
    Congenital bilateral scar-like lesions on the face.
    Br J Dermatol. 2020 Jul 21. doi: 10.1111/bjd.19328.
    >> Share

  791. ALFONSO JH, Martinsen JI, Weiderpass E, Pukkala E, et al
    Occupation and cutaneous melanoma: a 45-year historical cohort study of 14.9 million people in five Nordic countries.
    Br J Dermatol. 2020 Jul 6. doi: 10.1111/bjd.19379.
    >> Share

  792. DOIRON P
    Topical condyloma treatment: comparative evidence for a common problem.
    Br J Dermatol. 2020;183:5-6.
    >> Share

  793. ACHARYA P, Mathur M
    Low-dose naltrexone in Hailey-Hailey disease: the importance of dosing.
    Br J Dermatol. 2020;183:193.
    >> Share

  794. SHEN MX, Chen X
    Minimally important change: approach to interpretation of patient-reported outcomes.
    Br J Dermatol. 2020;183:8-9.
    >> Share

    June 2020
  795. VAN ZUUREN EJ, Arents BWM, Flohr C, Ingram JR, et al
    Publication of national dermatology guidelines as a Research Letter in the BJD: can less ever be enough?
    Br J Dermatol. 2020;182:1319-1320.
    >> Share

  796. FIFE K
    Hedgehog pathway inhibitors come of age.
    Br J Dermatol. 2020;182:1322-1323.
    >> Share

  797. WEISS JM
    Osteopontin regulatory functions in the hair follicle open a therapeutic approach for hypertrichosis.
    Br J Dermatol. 2020;182:1324-1325.
    >> Share

  798. LAIMER M
    Growth profile and anaemia in children with epidermolysis bullosa.
    Br J Dermatol. 2020;182:1327-1328.
    >> Share

  799. WEHNER MR
    Comparing the efficacy of field treatments for actinic keratosis: a critical appraisal of a randomized trial in the New England Journal of Medicine.
    Br J Dermatol. 2020;182:1343-1344.
    >> Share

  800. BELLON N, Hadj-Rabia S, Moulin F, Lambe C, et al
    The challenging management of a series of 43 infants with Netherton syndrome: unexpected complications and novel mutations.
    Br J Dermatol. 2020 Jun 1. doi: 10.1111/bjd.19265.
    >> Share

    May 2020
  801. REN F, Bai X, Elston DM
    Erythroderma in a newborn infant suggesting Omenn syndrome.
    Br J Dermatol. 2020 May 12. doi: 10.1111/bjd.19138.
    >> Share

  802. SCORER M, Setterfield JF, Harman KE
    Rituximab with prednisolone as first-line treatment in pemphigus vulgaris.
    Br J Dermatol. 2020;182:1078-1079.
    >> Share

  803. WALBURN J, Sarkany RPE
    Quality of life in the photodermatoses: the hidden toll of photosensitivity.
    Br J Dermatol. 2020;182:1077.
    >> Share

  804. THORNTON MJ
    Shedding more light on photoageing.
    Br J Dermatol. 2020;182:1086-1087.
    >> Share

  805. VAN LAARHOVEN AIM, Holle H
    Optimizing audiovisual itch induction: the role of attention and expectancy.
    Br J Dermatol. 2020;182:1088-1089.
    >> Share

  806. ELEWSKI B
    Rosacea treatment: a patient-centric approach.
    Br J Dermatol. 2020;182:1090-1091.
    >> Share

  807. STROWD LC, Feldman SR
    A hands-off approach may be more successful in treating chronic hand eczema.
    Br J Dermatol. 2020;182:1078.
    >> Share

  808. BASHYAM AM, Feldman SR
    Dermatology Life Quality Index: does improving the instrument make it better?
    Br J Dermatol. 2020;182:1082-1083.
    >> Share

  809. ARDELEANU M, Shumel B, Rossi AB, Graham NMH, et al
    Response to R. Waldman et al.: 'Does IL-4 inhibition play a role in dupilumab-associated conjunctivitis?'
    Br J Dermatol. 2020;182:1310-1312.
    >> Share

    April 2020
  810. DIZDAREVIC A, Troensegaard W, Uldahl A, Bergendorff O, et al
    Intervention Study to Evaluate the Importance of Information Given to Patients with Contact Allergy. A randomized, investigator-blinded clinical trial.
    Br J Dermatol. 2020 Apr 13. doi: 10.1111/bjd.19119.
    >> Share

    March 2020
  811. ROBERT J, Tavernier E, Boccara O, Mashiah J, et al
    Modalities of use of oral propranolol in proliferative infantile hemangiomas: an international survey among practitioners.
    Br J Dermatol. 2020 Mar 27. doi: 10.1111/bjd.19047.
    >> Share

    February 2020
  812. UTER W, Gefeller O, Mahler V, Geier J, et al
    Trends and current spectrum of contact allergy in Central Europe: Results of the Information Network of Departments of Dermatology (IVDK), 2007 - 2018.
    Br J Dermatol. 2020 Feb 27. doi: 10.1111/bjd.18946.
    >> Share

    November 2019
  813. GOLDBERG I, Mashiah J, Kutz A, Derowe A, et al
    Symptomatic mucosal involvement in pachyonychia congenita: the challenges in infants and young children.
    Br J Dermatol. 2019 Nov 28. doi: 10.1111/bjd.18742.
    >> Share

  814. HU C, Nijsten T, Pasmans SGMA, de Jongste JC, et al
    Associations of eczema phenotypes with emotional and behavioural problems from birth until school age. The Generation R Study.
    Br J Dermatol. 2019 Nov 15. doi: 10.1111/bjd.18705.
    >> Share

    September 2019
  815. LIMMER AL, Wu JH, Doan HQ, Rady PL, et al
    Acquired epidermodysplasia verruciformis: a ten-year anniversary update.
    Br J Dermatol. 2019 Sep 23. doi: 10.1111/bjd.18549.
    >> Share

    August 2019
  816. DENG PH, Wang CJ, Armstrong AW
    An Association between Hidradenitis Suppurativa and HIV.
    Br J Dermatol. 2019 Aug 13. doi: 10.1111/bjd.18433.
    >> Share

  817. BYRNE N, Hughes R, Murphy LA, Kirby B, et al
    Remission of severe hidradenitis suppurativa following chemotherapy for Hodgkin's lymphoma.
    Br J Dermatol. 2019 Aug 9. doi: 10.1111/bjd.18423.
    >> Share

  818. FELMINGHAM C, Yip L, Tam M, Nixon RL, et al
    Allergy to sunscreen and leave-on facial products is not a likely causative mechanism in frontal fibrosing alopecia - perspective from contact allergy experts.
    Br J Dermatol. 2019 Aug 1. doi: 10.1111/bjd.18380.
    >> Share

    July 2019
  819. MAILHE M, Tissot-Dupont H, Lagier JC
    Image Gallery: Atypical rash in an HIV-infected woman.
    Br J Dermatol. 2019 Jul 25. doi: 10.1111/bjd.18242.
    >> Share

  820. LEVY M, Martin L, Bursztejn AC, Chiaverini C, et al
    Ivermectin safety in infants and children under 15 kg treated for scabies: A multicentric Observational study.
    Br J Dermatol. 2019 Jul 25. doi: 10.1111/bjd.18369.
    >> Share

    June 2019
  821. MOLLANAZAR NK, Qiu CC, Aldrich JL, Tedaldi E, et al
    Use of Dupilumab in HIV-positive Patients: Report of Four Cases.
    Br J Dermatol. 2019 Jun 17. doi: 10.1111/bjd.18222.
    >> Share

  822. VAN LEERSUM FS, Seyger MMB, Theunissen TEJ, Bongers EMHF, et al
    Recessive mosaicism in ABCA12 causes blaschkoid congenital ichthyosiform erythroderma.
    Br J Dermatol. 2019 Jun 17. doi: 10.1111/bjd.18216.
    >> Share

    May 2019
  823. DESCHAMPS O, Ortonne N, Hue S, Rodriguez C, et al
    Acute exanthemas: a prospective study of 98 adult patients with emphasis of cytokinic and metagenomic investigation.
    Br J Dermatol. 2019 May 25. doi: 10.1111/bjd.18166.
    >> Share

  824. MASLIN D, Veitch D, Williams HC
    Direct infant UV light exposure is associated with eczema and immune development: A Critical Appraisal.
    Br J Dermatol. 2019 May 3. doi: 10.1111/bjd.18087.
    >> Share

    March 2019
  825. MORO R, Fabiano A, Mangeri F, Di Buduo A, et al
    Objective evaluation of infantile hemangiomas response to propanolol treatment using a 3D imaging system.
    Br J Dermatol. 2019 Mar 28. doi: 10.1111/bjd.17925.
    >> Share

  826. WANG CH, Chi MH, Lin JY, Chung WH, et al
    NUDT15 Polymorphism identified in an Azathioprine Hypersensitivity Syndrome Presenting as Erythema Nodosum and Hepatotoxicity.
    Br J Dermatol. 2019 Mar 6. doi: 10.1111/bjd.17859.
    >> Share

    February 2019
  827. WELFRINGER-MORIN A, Fraitag S, Balguerie X, Laaengh-Massoni C, et al
    Late ulceration of residual abortive infantile hemangioma: a rare complication.
    Br J Dermatol. 2019 Feb 4. doi: 10.1111/bjd.17717.
    >> Share

  828. HON KL, Ng WGG, Kung JSC, Cheng NS, et al
    Utility of Pediatric Allergic Disease Quality of Life Questionnaire for childhood eczema.
    Br J Dermatol. 2019 Feb 1. doi: 10.1111/bjd.17710.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016